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 1.0  Introduction 
Third molars when present are the last teeth to erupt into the oral cavity. As a result, there 
is often minimal space remaining to allow these teeth erupt into a functional position.  They 
are subsequently removed for a number of reasons; pericoronitis, unrestorable caries 
(including adjacent teeth), periodontal disease, and cystic changes. Elective removal of third 
molars may be warranted in cases where they impede prosthesis provision or prior to 
orthognathic surgery to help prevent an unfavourable saggital split (1). The impact of third 
molars on lower incisor crowding has been a source of much debate. Evidence accumulating 
over the last 20 years suggests third molars do not play a role in increased interdental 
pressure  (2, 3). Despite guidelines issued by the National Institute of Clinical Excellence 
(NICE) on the indications for the removal of third molars in 2000, third molar extraction 
remains the most common procedure carried out under general anaesthetic in Ireland (4).  
The treatment options given to patients on initial assessment largely depend on the facilities 
available to the clinicians, expected difficulty of the surgery, patient’s medical history, 
anxiety and preference(5). Patient satisfaction with general anaesthesia (GA) and its 
amnesic effects is no doubt a driving force for continued high rates of extraction under GA 
(6, 7).  For third molars removed in this manner, admission has changed from in-patient to 
outpatient care. In order for the definition of day-case to be adhered to, patients must be 
admitted and discharged on the same day.  Patients requiring removal of third molars are 
typically fit and healthy young adults (8) and suitable for ambulatory care. Pain is one of the 
main obstacles to predictable discharge(9, 10) and its control is the responsibility of both 
the surgeon and anaesthetist. Experienced surgeons may reduce post-operative pain and 
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swelling by minimising surgical trauma and time (11). Effective local anaesthesia to the area 
reduces post-operative pain (12, 13) 
Much research has been carried out to investigate the effect of local anaesthesia on post-
operative dental pain. Lidocaine and bupivacaine are two commonly used amide based local 
anaesthetic agents in dentistry. While latency times vary between studies (14, 15), they are 
in agreement that bupivacaine has a longer onset of action than lidocaine. Due to greater 
lipid solubility and protein binding (16), bupivacaine exhibits a longer duration of action, (14, 
17). Although bupivacaine may be expected to exhibit longer analgesia, the sensation of 
numbness is not always considered a pleasant sensation (17).  
Maximum pain after third molar surgery is typically felt during the first 8-12 hours (18, 19). 
Based on this fact, many studies have compared lidocaine and bupivacaine using the third 
molar pain model. Many of these studies used a “split-mouth” approach to compare these 
agents on the same patient but at different times (18, 20-22). This has the advantage of 
eliminating patient variables and reducing sample size. Split-mouth designs have been 
criticised due to “spill over” effects of the treatment and treatments being carried out at 
different times. This study was designed to prevent these flaws(23) and based on the fact 
that patients are better able to reliably compare two agents when their effects (or lack of) 
are recorded at the same time. All patients acted as their own control under the same 
operating conditions. 
Pain is subjective and non-surgical factors including individual and demographic factors have 
been shown to impact on pain experience (24). Individual factors include psychological 
variables such as a predisposition to catastrophize, as well as baseline levels of anxiety and 
11 
 
depression. Any surgery, including third molar removal can be stressful for a patient. The 
association between anxiety and pain is not a new one with several studies showing a 
positive correlation between greater levels of anxiety and post-operative pain (25-27). It is 
important to consider the role of anxiety and catastrophizing in patients due to have third 
molar surgery. Assumptions can be drawn from validated questionnaires to aid the clinician 
with surgical planning and anticipating pitfalls in the recovery period. 
Patient reported outcomes refer to information gained from patients and are central to a 
patient-centred approach to healthcare. Patient reported outcomes are distinct from 
patient based outcomes which may not necessarily come from the patient themselves. 
Outcomes measure a patient’s perspective of recovery in terms of lifestyle, pain and oral 
function, as well as other aspects related to the surgery (28). Third molar surgery is not 
without morbidity. Lifestyle interruption including ability to work lasts for ~3 days (29, 30). 
Analysis of patient reported outcomes may help provide a more specific outlook for the 
post-operative period for oral surgery patients. 
 Patient satisfaction is an integral part of modern healthcare. The Dental Visit Satisfaction 
Scale, developed by Corah et al in 1984,  assesses patient satisfaction with the dentist on 
one specific visit (31). Hence it is an appropriate tool to assess satisfaction with third molar 
surgery in this study as treatment was carried out on a single visit. Evaluating patient 
preference with different treatment modalities is often not a primary objective of research. 
In this study, pain scores as well as patient preference are considered. 
In conclusion, the purpose of this research is two-fold: 
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1. To determine if longer acting anaesthetic agent bupivacaine, has a prolonged effect 
on the period of acute postoperative pain when compared to shorter acting agent 
lidocaine. 
2. To determine patient’s post-operative satisfaction and preference with regard to 
anaesthetic choice. 
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2.0 Literature Review 
2.1 The Surgical Removal of Third Molars 
2.1.1 Third Molar Extraction 
Third molar extraction remains the most common procedure carried out under general 
anaesthetic in Ireland (4). Removal of third molars is primarily warranted due to the 
existence or risk of pathology. Pathology may include pericoronitis, unrestorable caries, 
periapical infection, cystic change or risk of caries to adjacent teeth. Since guidelines issued 
by the National Institute of Clinical Excellence (NICE) on the indications for the removal of 
third molars in 2000,removal of asymptomatic third molars has decreased (32). Despite 
these guidelines, there remains some dispute over prophylactic removal of third molars. Hill 
and Walker (33) looked at 427 lower third molars, which at initial assessment, did not 
require extraction according to NICE guidelines. These were monitored for 5 years and one 
third subsequently required extraction due to pericoronitis. 
2.1.2 Impacted teeth 
An impacted tooth is one that fails to erupt into the dental arch within a specific time. Third 
molars normally emerge into the oral cavity between 18-24 years, although there is a wide 
variation (34).  Impaction is primarily due to lack of sufficient space for eruption in the 
posterior maxilla and mandible (35) . The obstruction to the path of eruption can be caused 
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by hard (bone or tooth) or soft tissue. The impaction rate for third molars is higher than for 
any other tooth in the arch (36). There is large variation in the literature regarding the 
prevalence of impacted wisdom teeth. Dachi and Howell (36) examined 3,874 routine full-
mouth radiographs which found the incidence of impaction was 21.9 per cent for maxillary 
third molars and 17.5 per cent for mandibular third molars. A further study by Hugoson (37) 
reported a prevalence of impaction of at least one third molar as high as 72.7%.  
2.1.3 Assessment of Difficulty of Third Molar Surgery 
There have been many attempts to classify the type of impaction of third molars in order to 
predict operative difficulty.  Various extraction difficulty indices exist but controversy 
remains over their validity in predicting surgical outcomes.  A recent study has shown 
surgical difficulty prediction is not affected by surgeon experience (38). In 1926, Winter 
described the depth and angulation of the impaction using three imaginary lines (39, 40). In 
1933, Pell and Gregory predicted surgical difficulty radiographically, based on the depth of 
the third molar within bone, its relation to the ramus of the mandible and the long axis of 
the mandibular second molar.  This assessment has been shown to be insensitive in 
predicting surgical difficulty (41, 42). 
Winter’s assessment tool was further developed by MacGregor in 1985 to WHARFE, which 
includes Winter’s lines, height of the mandible, angulation, root morphology, follicle 
development and exit pathway (43).   
In recent years, more emphasis has been placed on patient variables to predict assessment 
of difficulty (44). Age is a significant factor, with studies showing surgical difficulty increased 
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with increasing age (39). Increasing age is associated with increased radiographic bone 
density and surgical difficulty according to Peterson (45).  Ethnic diversity and male gender 
have been shown to impact on surgical time and difficulty (46). Again, differences in bone 
properties are implicated as the reason for this (39). Arduous manipulation of the soft 
tissues in patients with increased body mass index can also increase surgical difficulty (47).  
There have been various efforts at determining a reliable model for assessment of difficulty. 
Although many have been postulated, none could be said to be universally acceptable. It is 
clear a combination of both radiographic and patient variables need to be considered when 
predicting difficulty of third molar surgery. Age, BMI, curvature of roots, and depth from 
point of elevation appear to be four of the most important variables to measure (47). 
2.1.4 Surgical Technique and Expertise 
Traditionally various methods have been used to remove third molars. A lingual split 
approach was routinely used which involved removing bone mesially and distally with a 
chisel and mallet to provide an application point, as well as splitting the lingual plate to 
allow delivery of the tooth. While post-operative pain and swelling has been shown to be 
less using this technique, there is also a greater risk of lingual nerve impairment (48). 
The most common procedure for removal of impacted third molars involves raising a full 
mucoperiosteal flap and the use of rotary burs with coolant to remove buccal bone to 
expose the tooth. The tooth is then often sectioned to avoid excessive bone removal (49). 
The piezoelectric technique was tested in oral surgery during the 1970s and has since gained 
a strong foothold in the surgical extraction of teeth including third molars. Advantages of 
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this technique include reduced postoperative swelling and trismus when compared to more 
conventional rotary osteotomy techniques (50). Another advantage of piezosurgery is its 
selective cut that recognises the hardness of tissues and works only on mineralised 
structures, so preventing damage to soft tissues including the mucoperiosteal flap and 
nearby blood vessels and nerves (51). The major disadvantage of this surgical technique is 
greater operative time it requires (52). Controversy exists in the literature whether such an 
increase in operative time is associated with increased pain levels (51, 53). 
It is widely acknowledged that surgical experience is a factor in reducing post-operative pain 
post third molar surgery (54). More experienced surgeons typically take less time to extract 
third molars than their junior colleagues (55). Longer operative procedures are typically 
associated with more pain.  
2.1.5 Normal Recovery 
Extraction of third molars is recognised by patients as a potentially painful procedure. Part 
of the informed consent process involves a discussion on the anticipated recovery period.  
Clinical and health-related quality of life (HRQOL) questionnaires have been used to 
evaluate patient’s perception of this post-operative period in terms of pain, lifestyle, oral 
function, and other symptoms related to the procedure (28, 56). Pain, difficulty eating and 
speaking, swelling and mouth opening are some of the variables that may be affected during 
this recovery period (56).   
Pain tends to be the most feared consequence of surgery from a patient’s perspective. 
Several studies have shown that pain will have reduced to “very weak” or “none” by the 
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seventh post-operative day (28, 56). While age has been shown to impact on surgical 
difficulty, it does not appear to correlate with increased pain and analgesic use (56, 57). 
Various analgesic regimes have been advocated to combat post-operative dental pain, with 
an expanse of research carried out on the topic. A non-steroidal anti-inflammatory (NSAID) 
used in combination with acetaminophen (paracetamol) has been shown to be superior to 
use of either drug alone (58). Corticosteroids used in combination with an NSAID have also 
shown increased efficacy (59, 60). NSAIDs provide analgesia by inhibiting the 
cyclooxygenase (COX) enzymes COX-1 and COX-2, enzymes which are needed for the 
production of inflammatory mediators such as prostaglandins, prostacyclins, and 
thromboxanes. Glucocorticoids exert their action at virtually every step in the inflammatory 
process, which leads to decreased capillary dilatation, decreasing circulating lymphocytes, 
inhibiting fibroblast proliferation, and inhibiting prostaglandins and leukotrienes (61). 
Corticosteroids can be administered by intra-muscular or submucosal route to similar effect 
(62), although debate exists in the literature whether submucosal administration has an 
effect on post-operative pain or trismus (60, 62). 
Lifestyle interruption, including time off work, is an important consequence of third molar 
surgery. Normal recovery requires an average of 3 days off work (29, 30). An interesting 
article by M. Colorado-Bonnin showed that greater  pre-operative information regarding 
post-operative complications was associated with increased time off work (63).  
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2.1.6 Complications 
Surgery is not without risks and complications. Complications can be intra-operative or post-
operative and can be associated with known risk factors. Intra-operative complications of 
lower third molar removal include bleeding, nerve injury, incomplete removal of roots, and 
fracture of the mandible. Post-operative complications include alveolitis, delayed healing, 
postoperative infection, hematoma, osteomyelitis, or persistent pain, or swelling (11). 
 The most common intra-operative complication is bleeding (11). Patients with risk factors 
for increased bleeding include those on anti-coagulants e.g. aspirin, warfarin and heparin 
(64), and those with inherited or acquired coagulopathies e.g Von Willebrands, haemophilia 
and thrombocytopenia. The type of anaesthesia used is an important decision when 
operating on patients with a known bleeding disorder (65). Fortunately, the vast majority of 
patients requiring removal of third molars are fit and healthy young adults (8). 
The most common post-operative complication is alveolar osteitis, more commonly known 
as dry-socket. Alveolar osteitis is identified by pain, increasing in severity in the post-
operative period, recognised by absence or partial absence of a blood clot. The incidence of 
this varies greatly within the literature, with incidence reaching over 30% for impacted 
lower third molars (66). Tobacoo use and operator inexperience have been implicated in 
higher rates of alveolar osteitis (67, 68). Various measures have been taken to reduce the 
incidence of alveolar osteitis including the use of dressings and chlorhexidine preparations 
and are well documented in the literature (69-71). To date, no single method has gained 
universal success or acceptance (72). 
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The inferior dental nerve (IDN) and lingual nerve (LN) often run in close proximity to lower 
third molars. Injury to these nerves can lead to a sensory deficit presenting as numbness to 
the lip/ chin and tongue respectively. Experience of the operator has been shown to impact 
on the incidence of nerve injury (57, 58).  
 The reported frequency of IAN injury associated with third molar removal ranges from 0.6% 
and 5.3% (73).Radiographic analysis is crucial in predicting the risk of surgical damage to the 
IDN, which is usually closely related to the apices of lower third molar roots. An 
orthopantomogram is the most commonly used radiographic view to determine if a third 
molar is intimately related to the IDN, and has proven to be effective (73). In cases where 
there appears to be an intimate relationship,  cone beam computed tomography (CBCT) has 
been shown to be more accurate in determining proximity (74).  
There is marked variation of reported LN injuries in the literature from 0% to 10% (75). The 
LN typically runs through the lingual mucosa medial to lower third molars. Injury to this 
nerve has been attributed to direct injury from the scalpel or perforating the lingual plate 
with a surgical bur (75). Lingual flap retraction is also thought to be responsible for LN 
damage and is not recommended for experienced surgeons (76, 77).  
Recent research has suggested administration of local anaesthetic may be a cause injury to 
these nerves. The aim of local anaesthetic administration for routine dentistry is to deposit 
the local anaesthetic close to the nerve, without inadvertent intraneural injection. Direct 
nerve injury can result in altered sensation or dysaesthesia, an unpleasant sensation (78). 
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On rare occasions, ~1%,  hospitalization is required for serious infections (79). The rate of 
admission for infection following prophylactic removal of third molars is low (80). Antibiotic 
prophylaxis to prevent postoperative infection is routinely undertaken in many centres with 
much literature published to support and oppose this practice (81, 82) .  
2.2 Anaesthesia in Oral Surgery 
2.2.1 The Choice of Anaesthesia in Third Molar Surgery 
The technique for removal of third molars varies little, whether carried out under local 
anaesthetic (LA), sedation or general anaesthesia (GA). The treatment options given to 
patients on initial assessment largely depend on the facilities available to the clinicians, 
expected difficulty of the surgery, patient’s medical history, anxiety and preference (29).  
For dentally anxious patients refusing treatment under LA only, conscious sedation is often 
sufficient for third molar extractions. In-office sedation is much more cost effective than GA 
(83). Despite this, the literature would suggest that there has been little decrease in the 
number of patients having third molars extracted under general anaesthetic (XGA). 
According to a prospective investigation of 522 patients having third molars removed in the 
Eastman Dental Hospital, 52% were operated on under GA.  A further 44% had extractions 
under LA and 3.5% had additional IV sedation(5, 29). Worrall et al. (7) found almost 70% of 
third molar extractions were carried out under GA, while less than a quarter were 
performed under local anaesthesia alone. Dunne et al.(84) found there was an increase in 
the number of patients having treatment under LA (31%-41%) +/- IV sedation (4%-13%) 
between 1995 and 2002. 
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2.2.2 Day Case General Anaesthesia 
Despite the continuing high number of extractions under GA, the trend has changed from 
the traditional inpatient care to day case surgery. The definition of day surgery in the UK 
and Ireland is clear: the patient must be admitted and discharged on the same day, with day 
surgery as the intended management (85) . In the UK, the Department of Health has guided 
the transition from traditional in-patient procedures to surgeries being performed on an 
outpatient basis, through the provision of an operational guide to day case surgery (86). 
While patients undergoing third molar surgery are typically young, fit and healthy, this does 
not mean patients with systemic disease cannot be treated on an outpatient basis. The 
Association of Anaesthetists of Great Britain & Ireland concludes fitness for a procedure 
should relate to the patient’s health as determined at pre-operative assessment and not 
limited by arbitrary limits such as American Society of Anaesthesiologists (ASA) status, age 
or BMI (85).  
Patient satisfaction with day case surgery has been investigated by Ross et. al. (87) who 
evaluated 106 patient’s preoperative attitude to third molar extraction under general 
anaesthetic as a day case. He found 96% of patients were happy to be treated as such.   
Postoperatively, 91% were satisfied. Pain and nausea were the two commonest reasons for 
dissatisfaction post-op.  
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In order to ensure patients are suitable and happy to be discharged on the day of surgery, it 
is crucial that post-operative pain and nausea is kept to as low a level as possible. This is the 
responsibility of both the surgeon and the anaesthetist. 
2.2.3 Local Anaesthetics in Dentistry 
The origins of local anaesthesia date back to 1884 when a young ophthalmologist, 
discovered that cocaine instilled into his own eye produced localised insensitivity to touch 
and injury (88) . Local anaesthesia in dentistry also began with the clinical use of cocaine 
(89). This promising but controversial discovery led to the development of ester and later 
amide type local anaesthetics. Nowadays, due to their superior characteristics, amide 
anaesthetics have completely replaced ester based anaesthetics in dentistry (90). Lidocaine 
and bupivacaine are commonly used amide anaesthetics used in medicine and dentistry.  
Local anaesthetics work by reversibly blocking voltage-gated sodium channels to prevent 
nerve conduction. To do this they must first cross the lipophilic lipoprotein membrane in a 
neutral unionised form. If a sufficient number of sodium channels are blocked, the threshold 
potential will not be reached and pain signalling is prevented (88).While the mechanism of 
action is the same for lidocaine and bupivacaine, they differ in their affinity to the sodium 
channels. Lidocaine binds and dissociates rapidly from the channel, whereas bupivacaine 
binds rapidly, but dissociates more slowly. The onset of action is directly related to the pKa 
of the local anaesthetic solution with smaller pKa values being associated with shorter 
latency. Bupivacaine has a pKa of 8.1 while lidocaine has a pKa of 7.7. Bupivacaine’s higher 
value means that a normal tissue pH of 7.4, it would have fewer free molecules to diffuse 
through the nerve membrane resulting in a slower onset time (14). 
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Lidocaine was first introduced in the market in 1948(91) and now comes available in 2% and 
3% solution, with or without epinephrine. Lidocaine remains the most commonly used 
anaesthetic, against which others are compared (20). Lidocaine (with epinephrine) has been 
shown to provide soft tissue anaesthesia from 50 minutes (dental pulp) to 120 minutes (soft 
tissue) (92). Latency time varies from ~2-3 minutes (93) to ~4-5 minutes (14)  depending on 
whether the onset of soft tissue or pulpal anaesthesia was tested. Max dose for lidocaine 
with epinephrine is 7mg/kg. 
Bupivacaine is also an amide but tends to have a longer duration of action due to its 
superior protein-binding characteristics (16). It demonstrates greater lipid solubility 
resulting in lower concentrations being required in practice to produce clinical effectiveness. 
Bupivacaine can provide analgesia during the first 8–12 hours depending on the strength of 
solution and presence of a vasoconstrictor (14, 17, 94). Latency time also varies according to 
testing criteria and varies from ~3 minutes (15) to ~6 minutes (14). Max dose of the drug 
(without adrenaline) is 2mg/kg. 
2.2.4 Lidocaine versus Bupivacaine 
A vast amount of research has been carried out to compare the efficacy of lidocaine and 
bupivacaine in dentistry. These local anaesthetic agents have been compared using the third 
molar pain model, as the pain model’s reproducibility has been well established (95). 
Many of these studies compare lidocaine and bupivacaine using the patient as their own 
control on separate occasions (20-22, 92, 96). The objectives of these studies varied with 
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few considering patient preference (21, 96).  The majority of these studies focused on pain 
relief provided by each anaesthetic on separate occasions (22, 97, 98).  
 Pain intensity following third molar surgery reaches a maximum between 3 and 5 hours 
following surgery (19). This would imply bupivacaine would be the anaesthetic of choice for 
third molar surgery, which is associated with prolonged periods of post-operative pain. A 
disadvantage of bupivacaine is the longer onset of action time, when compared to 
lidocaine(99), if treatment is carried out under LA only.  
2.3 Post-Surgical Pain 
2.3.1 Pain 
Pain is not simply a signal for tissue injury, but is primarily a signal to the organism to seek 
repair and recuperation.   –P. D. Wall(100) 
Pain associated with tissue damage or inflammation is described as nociceptive pain, which 
involves the normal neural processing of pain when free nerve endings are activated. 
Surgical incision leads to cell disruption and subsequent intracellular release of 
phospholipids and a state of widespread inflammation depending on the degree of surgical 
trauma (101). Nociception involves the processes of transduction, transmission, and 
perception. Tissue damage, such as surgery, releases chemical mediators, prostaglandins, 
bradykinin, serotonin, substance P, and histamine. These substances activate nociceptors, 
resulting in the generation of an action potential. The action potential is then transmitted 
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along afferent nerve fibres to the spinal cord. From the spinal cord it travels to the thalamus 
and midbrain and finally to several regions in the brain where pain is then “perceived” (102). 
2.3.2 Acute and Chronic Pain 
Acute pain is provoked by a specific disease or injury, serves a useful biologic purpose, and is 
self-limited (103).  Third molar removal typically requires surgery which results in tissue 
injury and moderate to severe post-operative pain. As third molar surgery is a common 
procedure, it is the model most used in acute pain trials (104).   
Patients become increasingly more sensitive to painful stimulus the longer the pain is 
uncontrolled (100). Hyperalgesia is the state where a painful stimulus causes more pain than 
normally expected. With increased irritation, nerve fibers normally not associated with pain 
sensation are recruited, with nonpainful stimuli now inducing pain; a state of allodynia 
(105). 
If acute pain is not managed appropriately, it may progress to chronic pain. Because 
definitions of chronic pain vary widely, chronic pain may be loosely described as pain that 
extends beyond the expected period of healing (106). Plasticity refers to changes that occur 
in the established nervous system in chronic pain. Injury, inflammation, and disease can all 
cause neuronal plasticity and increased pain by means of increased excitatory or decreased 
inhibitory mechanisms (107). Chronic pain post third molar removal is not a frequently 
occurring event (107). Nonetheless, it is imperative as clinicians that we recognize pain, as 
failure to do so can have detrimental effects on our patients (100). 
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2.3.3 Pain and Personality 
Pain is subjective, as can be explained by the same stimulus initiating different reactions in 
different individuals’ e.g local anesthetic administration. The concept of a “pain-prone” 
personality attempted to explain this phenomenon (108), but pain perception and 
interpretation is a more complex matter. 
Dental fear is one of the most frequent common fears (109), with fear of experiencing pain 
a constant worry, particularly for patients undergoing dental surgery(110). Such anxiety can 
be based on previous exposure to pain, experiences of family and friends or a general 
anxiety trait(111).  
Many attempts have been made to evaluate a patient’s predisposition to anxiety through 
use of questionnaires. In 1983, Zigmond and Snaith developed The Hospital Anxiety and 
Depression Scale (HADS) to identify anxiety disorders and depression in non-psychiatric 
hospital settings. This tool has proven to be brief, but as effective as other more arduous 
questionnaires (112, 113) in determining pre-existing anxiety and depression.  Other 
questionnaires such as Corah’s Anxiety Scale (DAS), and the Dental Fear Survey (DFS) (114) 
may aid in predicting how a patient may react to surgery.  
The anxiety scale of the State-Trait Anxiety Inventory (STAI) may be used to assess if the 
patient is predisposed to anxiety (114, 115) which may impact on the ability to carry out the 
intended treatment. 
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Studies have shown anxiety relating to the pain-inducing stimulus will exacerbate pain (116, 
117). It is important that anxiety prior to third molar surgery is addressed in order to foresee 
potential difficulties in the intra and post-operative period. 
The term catastrophizing was first introduced by Ellis in 1962 to describe mal-adaptive 
cognitive style employed by patients with anxiety or depression. Pain catastrophizing can 
impact on post-operative expectations and pain. It is described by Quartana et al as a 
“negative cognitive-affective response to anticipated or actual pain” (118). In 1995, O’ 
Sullivan et al developed a pain catastrophizing scale (PCS) which asks patients to reflect on 
previous painful experiences, in an attempt to foresee future problems and tailor individual 
treatment plans (119).  
It is important to consider the role of anxiety and catastrophizing in patients due to have 
third molar surgery. Assumptions can be drawn from these validated questionnaires to aid 
the clinician with surgical planning, and anticipating pitfalls in the recovery period. 
2.3.4 Pain and Gender 
Research in the area of pain and gender suggests that females have a greater propensity for 
experiencing and complaining of pain (120). Chronic pain conditions are more frequently 
reported by females than males (121). This study also suggests depression as a co-morbidity 
is twice as likely to occur in females as in males with chronic pain. 
So why do females report pain more frequently than their males counterparts? 
Sociocultural, psychological and biological factors are believed to be responsible (122). It is 
believed females are more likely to report pain and seek medical attention for pain related 
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matters (123, 124).  “Gender norms” may account for why males do not admit to pain as 
easily as women (125). 
Numerous animal and experimental studies have been carried out to investigate if a 
biological reason for these observed differences exist. It is generally well accepted that 
female rodents have a lower pain threshold to hot thermal, chemical, inflammatory and 
mechanical nociception (126). Animal studies have also speculated that female and male 
animals respond differently to opioid antinociception. Again conflict exists as to whether 
this is a one dimensional assumption that male animals have a more robust response to 
opioids, which does not take into account variation in animal strain and opioid receptor 
subtypes (126). The concept does suggest that analgesia should be tailored based on 
whether the patient is male or female.   
Animal research resulted in a change in American research policy in 1994 to ensure all 
human clinical trials had a representative female sample. This led to several studies which 
supported the evidence that females have less tolerance to noxious stimulation than their 
male counterparts (127). The reproductive and menstruation status of a female patient has 
been implicated in contributing to lower pain thresholds in females. Smith et al found higher 
pain reports during the low estradiol phase of the menstrual cycle (128). Conversely, high 
estradiol phases revealed similar pain thresholds to men (129). 
Many studies on post-operative pain following third molar surgery have revealed more post-
surgical pain in females than males (56, 130). Painkiller consumption however has not been 
shown to vary between male and female patients (54, 57). This may reflect the fact that 
situational and psychological factors can play a major role in symptom perception. 
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2.3.5 Pain Relief Regimes for Third Molar Extraction 
Pre-emptive anaesthesia is not a new phenomenon. The concept of pain prevention was 
first introduced by Crile in 1913, and further developed by Woolf in 1983. Pain associated 
with tissue damage results in prolonged modulation of the somatosensory system, with 
increased responsiveness of both peripheral and central pain pathways. Pre-emptive 
analgesia is a treatment that is initiated before and is operational during the surgical 
procedure in order to reduce the physiological consequences of nociceptive transmission 
provoked by the procedure.  It aims to provide analgesia to ‘pre-empt’ the 
neurophysiological and biochemical consequences of a noxious (painful or injurious) input 
to the CNS, rather than to begin treatment when these consequences are already 
established (131). 
 Theoretically, local anaesthetics administered prior to surgery commencing should prevent 
impulses being transmitted to the central nervous system. Gordon et al. (132) showed that 
preoperative local anaesthetic may reduce the post-operative demand for analgesics. 
Møiniche et al. (133) however carried out a systematic review of pre-emptive analgesia for 
postoperative pain relief. Results did not advocate implementation of pre-emptive 
analgesia. Similar results of studies involving third molar surgery suggest that pre-emptive 
analgesia using local anaesthetic  does not prevent the onset of pain but merely delays it 
(134). Wishing to clarify the theory of pre-emptive analgesia in third molar removal, Nayyar 
and Yates (18)  carried out a randomised controlled trial of 45 patients who had bilateral 
impacted third molars. These were treated under general anaesthetic and acted as their 
own control whereby bupivacaine was given to one side only. The opposite side did not 
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receive LA. The authors found that bupivacaine was effective in blocking peripheral 
nociceptors with a resultant reduction in postoperative pain. Differences in pain 24 h, 48 h 
and 7 days post-op were not significant however. 
Acute post-operative pain following third molar removal is largely treated with combination 
therapy. Paracetamol and NSAIDs provide mild to moderate pain relief, with opioids 
providing additional relief for severe pain (135). The benefits of this multimodal approach 
comes from the differing pathways in which these drugs combat pain. When using these 
combination analgesics one should still follow the principle of maximizing the non-opioid 
before adding the opioid. 
Paracetamol is considered an anti-pyretic analgesic drug with the advantage of having few 
adverse effects (136). Due to the lack of anti-inflammatory properties, paracetamol alone is 
not commonly considered to be sufficient for the treatment of post-operative pain following 
third molar removal (58). Some studies however have rejected this concept with a study by 
Bjørnsson et al showing comparable results in terms of post-operative pain and swelling 
following a three day regime of ibuprofen versus paracetamol (137). Paracetamol in 
combination with an opioid, typically codeine, has been shown to provide enhanced 
analgesia (136, 138, 139). 
NSAID’s have been used and studied extensively in all aspects of surgery; pre-, intra-, and 
post-operatively. Ibuprofen, diclofenac sodium and (dex)ketoprofen are commonly 
prescribed for their analgesic properties. Ibuprofen tends to be the drug of choice when 
comparisons are made between NSAID’s and placebo or other drug groups, and has a long 
history in the dental setting (140-142). Ibuprofen can be purchased over the counter and 
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has less adverse effects than other traditional NSAID’s (143). Conventional NSAID’s e.g 
ibuprofen, diclofenac and naproxen, are non-selective and have a propensity for adverse 
gastrointestinal events. This is believed to be caused by impairment of prostaglandin 
induced mucosal protective mechanisms (144). Selective COX 2 inhibitors e.g rofecoxib and 
celecoxib have been developed to reduce these adverse effects, but long term high dose use 
has been associated with increased incidence of myocardial infarction and stroke (145). Pain 
post third molar surgery is typically relatively short in duration and therefore traditional 
NSAID’s can be utilised without major risk of serious gastrointestinal injury. 
Opioids are used for relief of moderate to severe dental pain, often in combination with 
paracetamol and a NSAID (146). Opioids act on three major receptors on neuronal cell 
membranes; mu, delta and kappa to prevent neurotransmitter release causing analgesia 
(147). Tramadol is stronger than codeine or a paracetamol/ codeine combination (148), and 
can be used effectively for break through pain post third molar surgery (149, 150). Fentanyl, 
a short acting opioid can be used at induction of general anaesthetic or for post-operative 
pain relief (151). The use of opioids should be restricted due to significant side effects. All 
opioids result in dose dependent respiratory depression, constipation, nausea and vomiting, 
and sedation, as well as mood disturbance and dependence in certain cases (152).  
There is no gold standard for pain relief following third molar surgery with ongoing dispute 
over the most effective pharmacological management (136). Prescribed analgesia should be 
tailored depending on age, co-morbidities, surgical difficulty on a case by case basis. 
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2.3.6 Pain Assessment 
Pain is an expected outcome of surgery, and one that requires measurement. With an 
abundance of tools available to measure patient outcomes, Fitzpatrick et al (153) have 
provided a framework to choose the correct instrument through the provision of 8 criteria. 
They believe the chosen instrument should be; 
 appropriate, i.e. it should match the specific purpose of the study; 
 reliable, in terms of reproducibility and internal consistency; 
 valid, in that it measures patients’ perceptions of pain; 
 responsive to changes of importance to patients; 
 precise (accurate and discriminating); 
 interpretable, in that meaningful scores are produced; 
 acceptable to those completing it;  
 feasible, i.e. the degree of burden and effort involved in using it is acceptable. 
The Verbal Descriptor/ Rater Scale (VD/RS) was devised by Keele in 1948 using three to five 
numerically ranked words to indicate level of pain e.g. “none”, “mild”, “moderate”. This has 
since been adapted and used in combination with various questionnaires and other pain 
measures (154). While still popular, patients are restricted to using one word only to 
indicate pain intensity. Different pain thresholds and subjectivity may result in ambiguous 
results.  
The Numerical Rating Scale (NRS), devised by Downie et al in 1978 (155), describes pain as a 
numerical value with 0 indicating no pain and 10 indicating severe pain.  A NRS has the 
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advantage of using numbers rather than words, which can be interpreted differently. A 
sound knowledge of the English language is also unnecessary. This tool may be limited for 
use with those of extremes of age (154). 
 
 
The Visual Analogue Scale was developed in 1978 by Maxwell et al. It consists of a 100mm 
horizontal line with anchors at each end. The left end represents no pain, with the right side 
representing unbearable pain. Patients are asked to make a mark on the line to indicate 
their level of pain. The mark is then measured in mms which can then be analysed by a 
researcher using parametric tests. In contrast to the VDS and the NRS, patients need not 
express their level of pain using a discrete word or number. Non-parametric tests are 
required for ordinal data produced by VDS and NRS, which are less sensitive than parametric 
tests used for analysis of VAS data. Concern however has been raised over its use in the 
post-operative period if the patient has had a general anaesthetic, due to potential nausea 
and visual disturbance affecting its completion (156). Despite the range of tools available,  
the VAS is still the preferred method used for measurement of a patient’s pain (157).  
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Pain assessments help guide the provision of analgesics post-surgery. However results of 
such assessments do not always correlate with a requirement for analgesics (158). 
In order to gain a more rounded view of pain, questionnaires are often utilised. The McGill 
Pain Questionnaire is another self-reporting method, used to demonstrate and address the 
multidimensional nature of pain. Developed by Melzack, in its full form it is divided into 
three categories to evaluate patient pain; sensory, affective and evaluative (159). It provides 
quantitative measures of clinical pain which can be analysed statistically. Where time is 
limited, and a short form is now available which has shown to be as reliable as the original 
(160). Prediction of post-operative pain using an electrical pain stimulus has been used in 
other medical settings (161) but has not been tested using the third molar pain model. 
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2.4 Patient Satisfaction and Third Molar Surgery 
2.4.1 Patient Satisfaction 
In 2012, the Health Information and Quality Authority (HIQA) of Ireland developed National 
Standards for Safer Better Healthcare (162). “Person- centred care and support” was one of 
the key themes discussed. In order to fulfil this recommendation, it is advised that patients 
be at the core of all aspects of health provision. Input from service users should be sought in 
the planning and design of healthcare services, and feedback mechanisms should be in place 
in order to review and improve services provided.  
These recommendations led the Health Service Executive (HSE) to release a staff guide for 
using patient feedback to improve health services(163). As satisfaction is subjective, the HSE 
have advised patient experience be the measures outcome, rather than patient satisfaction. 
This is to be done through use of quantitative patient experience surveys, analysis of 
received complaints, population surveys and forums, and focus groups. Using a range of 
these methods leads to a well-rounded insight into patient experience of service provision.  
Patient satisfaction affects clinical outcomes, malpractice claims and patient retention (164). 
Feedback can be used to facilitate changes to improve provision of care at various levels 
within a health system. Likewise, poor patient satisfaction correlates to increased litigation 
(165, 166). Nowadays patient dissatisfaction can all too quickly progress to litigation. 
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However a dissatisfied patient is less likely to instigate legal proceedings if they have had 
prompt, clear communication following a complaint(167).  
Studies on the deterioration of a patient’s quality of life following surgery for removal of 
third molars has been well documented over the past twenty years (168, 169). Patient 
satisfaction is more likely once they have been given sufficient information regarding the 
procedure and post-operative period (170). 
2.4.2 Patient Education 
Providing patients with sufficient information before a procedure is carried out is a 
fundamental and legal aspect of dental surgery. Patients are educated regarding their third 
molar surgery and post-operative effects at consultation, often with a combination of oral 
and written explanations. Video modelling to aid patient’s decision making has been shown 
to be successful (171, 172), however video demonstrations to provide information prior to 
third molar surgery has been shown to increase anxiety (170). 
Three types of coping styles exist; vigilant, avoidant and fluctuating coping (173). “Vigilant” 
patients are those who benefit from obtaining as much information as possible, and in 
whom information reduces anxiety. Avoidant copers avoid excess information as knowledge 
increases anxiety. Fluctuating copers fall between the two categories. Baume et al (174) 
found avoidant copers were less anxious during dental surgery.  
Conflicting theories exist regarding the effect the process of informed consent has on 
patients awaiting third molar surgery. Torres et al (175) found verbal and/ or written 
information had no patient reported effect on anxiety prior to third molar surgery. On the 
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other hand, Casap et al (176) found statistically significant changes in physiological 
parameters in patients who received detailed informed consent, compared to another 
group who were given a simplified version. 
A delicate balance exists between providing enough information in order to give informed 
consent, and giving too much information which may deter a patient from going ahead with 
a necessary surgery. An assessment should be made by the clinician to decide how much 
information should be given. With information being readily available via the internet, 
patients are often over informed. Clinicians should be aware that patients may be obtaining 
information of variable quality online and should be prepared to offer suggestions for 
reliable online resources for those patients (177). 
Patient education is required from a medico-legal, as well as patient care point of view. 
Patients given sufficient postoperative preparatory information are more likely to be 
satisfied in the post-operative period, as well as reporting less pain (170). 
2.4.3 Measurement tools for Patient Satisfaction 
Donabedian’s name is synonymous with the concept of quality assessment in healthcare, a 
notion first described in 1966 (178) and built on by further research (179-181). Patient 
satisfaction is a core element of assessment of quality in these studies and is now 
mandatory in many countries (182). Its definition is as controversial as the way in which it 
should be measured. Patient satisfaction has been variously defined as ‘an individual’s 
positive evaluations of distinct dimensions of health care’ (180) and more recently as the 
“extent of an individual's experience compared with his or her expectations”(183). Patient 
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satisfaction may be interpreted as subjective and objective. For example waiting time can be 
measured objectively in hours/ days and also interpreted subjectively by a patient who may 
feel this waiting time was longer/ shorter than expected (184). Patient socio-demographics 
have been shown to influence patient satisfaction outcomes. Greater age and lower 
education have shown significant association with greater satisfaction with medical care 
(184, 185). Patient- practitioner interaction has also been shown to impact greatly on overall 
patient satisfaction with a service (186, 187). 
Feedback can be solicited from patients in a variety of ways: phone surveys, written surveys, 
focus groups or personal interviews (188). The issue of social desirability, for example 
participants providing a response they feel is more desirable or socially expected, is debated 
in the literature with conflicting evidence as to whether or not it exists (189, 190). 
Questionnaires have been the most common assessment tools for recording patient 
satisfaction (191). These can be carried out via telephone, interview based or patient self-
completing and all are expected to yield equivalent responses (192). Standardised 
questionnaires have the advantage of greater validity and reliability, however the range of 
questions available are limited. Private vendors often provide questionnaires for inpatient 
care, while in-house compilations of standardised and private questionnaires are often used 
for feedback of outpatient services  (182).   
Involvement of patient opinion in the Irish health care system stems from the health 
strategy “Quality and fairness: a health service for you’ (193). Work has been carried out to 
standardise how feedback is recorded, however the majority of studies have focused on 
inpatient care. To address this, the Royal College of Surgeons Ireland published 
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recommendations for developing and using questionnaires to capture patient feedback with 
outpatient services (190). This document advises questions be clearly numbered or 
sequenced, logical and easily understandable by patients, and as short as possible. An 
example of such is the dental visit satisfaction scale (DVSS). 
The DVSS was developed by Corah et al in 1984 to assess patient satisfaction with the 
dentist on one specific visit (31). Hence it is an appropriate tool to be used to assess 
satisfaction with third molar surgery which is often carried out in a single visit. The 
questionnaire assesses satisfaction using three subscales; information/communication, 
understanding/acceptance and technical competence. An overall measure of satisfaction 
was also addressed. Patients rate their response to standardised statements on a 5 point 
scale, each of which is allocated a score that can then be analysed. 
2.4.4 Patient Reported Outcomes in Third Molar Surgery 
Patient reported outcomes refers to information gained from patients. It is distinct from 
patient based outcomes which may not necessarily come from the patient themselves. 
Outcomes measure a patient’s perspective of recovery in terms of lifestyle, pain and oral 
function, as well as other aspects related to the surgery (28).  
Outcomes are normally evaluated through use of questionnaires. In 1994, a 49 point 
questionnaire developed by Slade it al (194) evaluated the dysfunction, disability and 
discomfort associated with oral conditions. This was then condensed to a 14 point 
questionnaire in 1997.  In 1999, Conrad et al (56) developed a 21 point quality of life 
questionnaire to assess patient’s perception of recovery following third molar surgery. Four 
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main areas were assessed using Likert type scales: lifestyle, oral function, general activities 
and other symptoms.  
Various versions and adaptations of these oral health impact profiles exist which all aim to 
provide a more holistic approach to understanding what a patient will expect following 
dental surgery. Such feedback is also important for clinicians providing accurate information 
for informed consent. 
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2.5 Summary of the Literature Review 
2.5.1 The Surgical Removal of Third Molars 
 Despite guidelines introduced by the National Institute of Clinical Excellence (UK), 
third molar surgery remains the most common procedure carried out under general 
anaesthetic in Ireland. 
  Pericoronitis, associated pathology and caries are the most common reasons for 
extraction. 
 Assessment of difficulty is based on the nature of impaction both clinically and 
radiographically, as well as patient variables such as age, gender, race and BMI. 
 Pain and swelling is dependent on surgical technique as well as operator experience.  
Such morbidity is responsible for an average of 3 days off work. 
 Complications of surgery include bleeding, iatrogenic nerve damage, incomplete 
removal of roots, and fracture. Alveolar osteitis is the most common inflammatory 
complication. 
2.5.2 Anaesthesia in Oral Surgery 
 Choice of anaesthesia largely depends on the facilities available, expected difficulty 
of the surgery, patient’s medical history, anxiety and preference. 
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 Patients undergoing third molar surgery are typically young, fit and healthy and are a 
suitable cohort of patients for day case surgery. Consistent discharge is dependent 
on the absence of pain and nausea. 
 Pain intensity following third molar surgery reaches a maximum between 3 and 5 
hours following surgery. 
 Lidocaine and bupivacaine are commonly used amide anaesthetics in third molar 
surgery. Bupivacaine has a longer onset and duration of action. 
2.5.3 Post-Surgical Pain 
 Third molar removal typically requires surgery which results in tissue injury and 
moderate to severe post-operative pain 
 Pain is subjective and the concept of a “pain-prone” personality attempts to explain 
how patient variables affect post-operative pain. Females experience greater pain 
than their male counterparts following third molar surgery. 
 It is important to consider the role of anxiety and catastrophizing in patients due to 
have third molar surgery. 
 Evidence for pre-emptive analgesia is equivocal. 
 There is no gold standard for pain relief following third molar surgery with ongoing 
dispute regarding the most effective pharmacological management. A multimodal 
approach is the typical means to achieve effective pain relief. 
  Prescribed analgesia should be tailored depending on patient factors, and surgical 
difficulty on a case by case basis. 
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 Despite the range of tools available, the VAS is still the preferred method used for 
measurement of patient’s pain for scientific research. 
 The McGill Pain Questionnaire is a self-reporting method, used to demonstrate and 
address the multidimensional nature of pain. 
2.5.4 Patient Satisfaction and Third Molar Surgery 
 “Person- centred care and support” ensures patients are at the core of all aspects 
of health provision. 
 Patient satisfaction is more likely once they have been given sufficient 
information regarding the procedure and post-operative period. 
 Standardised questionnaires have the advantage of greater validity and 
reliability, however the range of questions available are limited. 
 The Dental Visit Satisfaction Scale assesses satisfaction using three subscales; 
information/communication, understanding/acceptance and technical 
competence. 
 Patient outcomes measure a patient’s perspective of recovery in terms of 
lifestyle, pain and oral function, as well as other aspects related to the surgery. 
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3.0 Methodology 
Following a review of the literature we decided to carry out a prospective interventional 
clinical trial to examine the differences in pain perception comparing lidocaine to 
bupivacaine in terms of patient satisfaction. 
3.1 Aims 
The aims of the study were twofold: 
1: To determine patient’s post-operative preference and satisfaction with regard to 
anaesthetic choice. 
2: To determine if longer acting anaesthetic agent bupivacaine, has a prolonged effect on 
the period of acute postoperative pain when compared to shorter acting agent lidocaine. 
3.2 Hypotheses 
1. H0: There is no difference in patient satisfaction and preference when lidocaine is 
compared to bupivacaine for removal of third molars. 
H1: There is a difference in patient satisfaction and preference when lidocaine is 
compared to bupivacaine for removal of third molars. 
1. H0: There is no difference in level of pain experienced by patients following surgery 
when lidocaine is compared to bupivacaine.  
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H1: There is a difference in level of pain experienced by patients following surgery 
when lidocaine is compared to bupivacaine. 
3.3 Ethical Approval 
Ethical approval was obtained from the Clinical Research Ethics Committee Cork in April 
2013. This study commenced in May 2013. 
3.4 Sample size  
The very approximate standard deviation of VAS score difference (s.d.=22) from an 
unpublished study to compare lidocaine with ‘no anaesthetic’ was used in determining an 
approximate sample size. To allow for a difference of 10mm VAS to be seen in the 3-8 hours 
post-operatively, and for a non-compliance rate of 30%, 80 patients were required in order 
to achieve a power of 90% at the 5% level of significance.  
3.5 Recruitment 
  85 ASA I or II patients having both similarly impacted lower third molars teeth surgically 
extracted under general anaesthetic were recruited following informed consent, (Appendix 
I). 
Exclusion criteria: 
 Use of analgesics for any reason within 24hrs of the operation 
 Pre-existing pain conditions other than that relating third molars 
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 Pregnancy, poorly controlled systemic disease e.g diabetes & hypertension, 
psychiatric illness, neurological disease, learning difficulties 
 Prisoners 
 Patient refusal 
3.6 Method 
Standardised general anaesthetic was provided by one of two experienced anaesthetists. 
Standard monitoring was in place including pulse oximetry, electrocardiography, non-
invasive arterial blood pressure, and monitoring of inspired and end-tidal partial pressures 
of sevoflurane, carbon dioxide and oxygen. Anaesthesia was induced using propofol and 
maintained using clinically indicated concentration of sevoflurane in an oxygen/air mixture. 
Muscle relaxation was achieved with atracurium and the patients’ tracheas intubated with 
an appropriately sized nasal endotracheal tube. 
 
Standard preoperative analgesia included solpadeine (paracetamol and codeine), diclofenac 
sodium and oxycontin.  Intraoperative analgesia included intravenous fentanyl. 
Dexamethasone 8mg IV was administered routinely as an antiemetic. Further analgesia 
(tramadol, fentanyl or morphine) was administered postoperatively as required. 
 
Bilateral wisdom tooth removal was carried out by one experienced surgeon. The 
anaesthetic containing 2% lidocaine with 1:80000 adrenaline was administered on one side 
of the mouth. A 2.2 ml cartridge was administered as an inferior dental block, with a further 
2.2ml administered as a buccal infiltration.  
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0.5% plain bupivacaine (marcain) was administered on the opposite side of the mouth. 5ml 
of solution was drawn up in a 5ml syringe from a 10ml bottle.  2ml was administered as an 
inferior dental block using a 22 gauge needle and a further 2ml administered as a buccal 
infiltration. Extractions involved incision/ raising of a full mucoperiosteal flap, ± buccal bone 
removal, ± tooth division. All sockets were irrigated with saline and sutured using 4.0 vicryl. 
 
In each case the surgeon completed a standard pro forma post operatively to allow 
comparison of right and left third molars. This included: 
 State of eruption (partially erupted, unerrupted) 
 Type of impaction based on Winters classification system (vertical, mesioangular, 
distoangular, horizontal) 
 Technique employed (elevation only, bone removal and elevation, bone removal, 
tooth division and elevation) 
 Duration of surgery 
At discharge all patients were given standard post-operative instructions and received a 
prescription for paracetamol 500mg two tablets 6 hrly orally, dexketoprofen 25mg tablet 8 
hrly orally, and oxynorm 5mg 6hrly orally as required for three days. 
3.7 Data Collection 
Patient demographics including patient’s date of birth, gender, ASA grade, contact details 
and smoking status were recorded preoperatively. The following assessments were carried 
out by a single investigator (CMC): 
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The McGill Pain Questionaire (short form) (SFMPQ), Pain Catastrophising Scale (PCS), and 
Hospital Anxiety and Depression Scale (HADS).These were applied preoperatively and 
repeated at discharge.   
Pain assessment using a 100mm visual analogue scale (VAS) was used to assess pain for 
both right and left sides independently. This was carried out by the patient immediately 
post operatively, at 30mins, and at 1 hour prior to discharge (phase I) (Appendix II).  VAS 
was marked at 3, 4, 6, and 8 hours on the day of surgery (phase II) (Appendix III), and every 
24 hours for seven days (phase III). These were used to compare the pattern and level of 
pain experienced on both sides.  
Additional analgesic use and satisfaction were recorded prior to discharge. Satisfaction 
ratings were assessed using a modified version of the Dental Visit Satisfaction Scale (DVSS). 
This included a free text section to comment on matters not covered.  
Each patient included in the study was given a pain diary to complete nightly for 7 days 
following surgery, and a further DVSS to complete on the 7th postoperative day (POD). The 
pain diary consisted of VAS pain scores for right and left sides of the mouth, a record of 
analgesic consumption and impact on daily life. All patients were contacted by telephone or 
email one week following surgery to determine whether they were still experiencing any 
adverse outcomes and to ensure return of the pain diary by post.  
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3.8 Statistical Analysis  
Data was analysed using SPSS 18.0 (SPSS, Chicago, Illinois, USA). Frequency counts, 
percentages, means, standard deviations, medians and quartiles were used to summarize 
data. Data was assessed for normality using histograms, Normal Q-Q plots and the Shapiro 
Wilk tests. The Shapiro Wilk test was not used to test for normality for variables with 
relatively few distinct values. In such cases normality was judged graphically. Differences 
were computed for paired data and tested for normality.  A bootstrap paired samples test 
(based on 5,000 bootstrap samples) was applied when differences were not normally 
distributed and where suitable transformations were not found. Many of these difference 
variables were rejected for normality due to either skewness or kurtosis. Although the 
paired t-test is robust to violations of the normality assumption and similar conclusions 
would be reached using the test, we opted to report the more accurate bootstrap 
significance levels and confidence intervals where applicable.  
“Bootstrapping is a method for deriving robust estimates of standard errors and confidence 
intervals for estimates such as the mean, median, proportion, odds ratio, correlation 
coefficient or regression coefficient.”  It may also be used for constructing hypothesis tests. 
Bootstrapping is most useful as an alternative to parametric estimates when the 
assumptions of those methods are in doubt….”  SPSS 
 Group comparisons of highly skewed variables and ordinal data were analysed using the 
Wilcoxon signed-rank test and the Kruskal- Wallis test as appropriate. For categorical 
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variables Chi-squared test was performed. Spearman’s Rho correlation coefficients were 
computed to test for association between highly skewed interval and/or ordinal variables.  
All statistical tests were two-tailed. 
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4.0 RESULTS 
4.1  Demographics 
4.1.1 Age 
Eighty five patients were enrolled in this study. Age ranged from 16 to 44 years with a 
median age of 20.3 (lower quartile 17.7 years, upper quartile 26.25 years), Table 1. 
Table 1: Age Groups of Study Participants 
Age Frequency Percentage 
16-20 46 54.1 
21-25 17 20 
26-30 18 21.2 
31-35 2 2.4 
36-40 1 1.2 
41-45 1 1.2 
Total 85 100 
 
4.1.2 Gender 
There were 26 males and 59 females enrolled in the study accounting for approx. 30% and 
70% respectively, as shown in Table 2. 
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Table 2: Gender of Study Participants 
Gender Frequency Percentage 
Male 26 30.6 
Female 59 69.4 
Total 85 100 
 
4.1.3 ASA Grade & Smoking Status: 
This study was limited to ASA I and II patients. Over 90% of these patients were ASA grade I 
representing a healthy cohort of patients.  
Non-smokers accounted for 88% of the overall number of subjects, Table 3 
Table 3: Smoking Status of Study Participants 
 
 
 
 
A test for association was conducted between ASA grade and smoking status (Table 4) and 
this was statistically significant (Fishers Exact Test; p= 0.049). Results revealed 3/10 (30%) of 
Smoker Frequency Percentage 
Yes 10 11.8 
No 75 88.2 
Total 85 100 
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smokers were ASA 2, compared to 5/75 (6.7%) of non-smokers. However according to Phi 
this association is weak p= - 0.257. 
Table 4: ASA Grade by Smoking  
ASA Smoker Non-Smoker Total 
1 7 70 77 
2 3 5 8 
Total 10 75 85 
 
4.2 Pre-operative assessment 
4.2.1 Pre-Operative Pain Catastrophizing Scale 
A Pain Catastrophizing Scale (PCS) was used pre- and post-operatively to detect those study 
participants who may be predisposed to catastrophizing or viewing a situation as 
considerably worse than what it actually is. This questionnaire includes 13 statements which 
refer to the thoughts and feelings of those who are in pain (Appendix IV). 
Each statement is rated on a scale of 0 to 4. The maximum score for the questionnaire is 52. 
The higher the score, the more likely the patient is to catastrophize. A score of 30 or more is 
thought to be clinically relevant.  In this study, 8.4% of patients scored above this level. 
Table 5 outlines the descriptive statistics computed following analysis of PCS scores.   
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Table 5: Descriptive Statistics PCS Scores 
N 85 
Median 11 
Minimum 0 
Maximum 38 
Percentiles 25 5 
50 11 
75 22 
 
4.2.2  Pre-Operative Hospital Anxiety and Depression Scale 
A questionnaire to determine the level of anxiety and depression experienced by patients 
participating in the study was completed pre- and post-operatively. The Hospital Anxiety 
and Depression Scale (HADS) is a questionnaire with 14 statements, 7 relating to anxiety, 
and 7 relating to depression (Appendix V). 
For each question patients were asked to tick one of the four options which best described 
them. Each item is scored from 0-3 with a maximum score of 21 for both anxiety and 
depression. A score of 8/21 is considered “borderline” for either anxiety or depression, with 
a score > 11 representing “moderate” psychological morbidity.  See Table 6 and Table 7 for 
“anxiety” and “depression” subsets respectively. 
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Table 6: Pre-op HADS Anxiety    
Pre-op HADS Anxiety Frequency Percent 
Normal (0-7) 79 92.9 
Borderline (8-10) 6 7.1 
Total 85 100 
 
Table 7: Pre-op HADS Depression 
Pre-op HADS Depression Frequency Percent 
Normal (0-7) 79 92.9 
Borderline (8-10) 6 7.1 
Moderate (>11) 2 2.4 
Total 85 100 
 
4.2.3  Pre-Operative Short Form McGill Pain Questionnaire 
The Short Form McGill Pain Questionnaire (SF-MPQ) consists of 15 descriptors of pain which 
are rated on an intensity scale (Appendix VI). Eleven of these are sensory descriptors while 
the remaining 4 are affective terms.  All patients were asked to indicate the level of pain 
they were experiencing at that moment in time by ticking the appropriate circle ranging 
from “none” to “severe”. Each question was scored from 0-3 with a maximum score of 33 
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for the sensory subset, and a maximum of 12 for the affective subset. Three pain scores 
were calculated and are shown in Table 8. 
1. The sum of the intensity rank values for sensory words chosen  
2. The sum of the intensity rank values for the affective words chosen  
3. The total sum of the descriptors (sensory & affective)  
Table 8: Frequency Distribution of Pre-Operative SF-MPQ  
Score Sensory Affective Sum total of sensory and affective 
0 74 (87%) 79 (93%) 70 (82%) 
1-6 11 (13%) 6 (7%) 14 (17%) 
7-12 0 (0%) 0 (0%) 1 (1%) 
 
4.2.4 Effect of Pre-Operative Assessments on Pain Scores  
Spearman’s Rho (rs) was used to measure the strength of the association between two 
variables where the values were ranked. 
There was no evidence of an association between pre-operative PCS scores and total phase I 
VAS scores (rs =0.107; p= 0.343). 
Greater total phase I VAS scores were not associated with higher HADS scores for anxiety 
and depression. Spearman’s correlation coefficient, based on original data of Vas Phase I 
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and HADS pre-anxiety and depression were rs = 0.181 and rs = -0.061, respectively and both 
were not statistically significant. 
There was no evidence of an association between VAS for phase I and pre-operative sensory 
(rs =-0.147; p= 0.194), affective (rs =0.054 p= 0.633) and total sum (rs = -0.080; p= 0.479) 
MPQ scores. 
 
4.3 Third Molar Assessment 
4.3.1 Classification of Third Molars 
Winters classification for lower third molars was recorded by the surgeon for each case. 
Here 81% (69/85) of cases were symmetrical, Table 9.  
Table 9: Winters Classification Comparing Right and Left Third Molars 
 Left Third Molar  
Total 
Vertical Mesioangular Distoangular Horizontal 
Right 
Third 
Molar 
Vertical 21 1 1 1 24 
Mesioangular 5 36 2 2 45 
Distoangular 0 2 8 1 11 
Horizontal 0 1 0 4 5 
Total 26 40 11 8 85 
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4.3.2 Surgical Technique 
Surgical technique was recorded by the surgeon for each case. Surgical technique was 
identical in 74% of cases. Of the 16 asymmetrical third molars (according to Winter’s 
classification), 9 (56%) had different techniques employed on the right and left sides (Error! 
eference source not found.).  
Table 10: Surgery Technique of Right and Left Molars 
 Left Third Molar  Total 
E TS & E 
(Osteotome) 
TS & 
E 
BBR & 
E  
BBR, TS 
& E 
 
Right Third 
Molar 
E  12 2 0 2 2 18 
TS & E 
(Osteotome) 
2 4 0 0 1 7 
FLAP & E 0 1 0 0 0 1 
TS & E 1 0 1 0 0 2 
BBR & E 3 0 0 11 5 19 
BBR, TS & E 3 0 0 1 34 38 
Total 21 7 1 14 42 85 
 
To determine if post-operative pain severity was influenced by surgical technique, VAS 
scores for phases I, II and III were averaged for those with three scores. These composite 
scores were compared across surgical technique in order of increasing surgical difficulty 
separately for bupivacaine and lidocaine. There was a positive and significant correlation 
(Spearman’s rho= .308, p= .010) between ordered surgery type and VAS scores during phase 
II for the lidocaine side. A similar but non-significant trend was observed for bupivacaine. 
The range of the mean rank scores were similar for both groups, see Table 11 and Table 12 . 
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Table 11 Mean Rank VAS Scores/ Surgical Technique: Lidocaine 
 Lidocaine N Mean Rank 
Phase I E 19 38.66 
TS (Osteotome) & E 7 41.50 
BBR & E 15 49.10 
BBR, TS & E 40 38.99 
Total 81  
Phase II E 16 26.94 
TS (Osteotome) & E 7 27.14 
BBR & E 12 33.67 
BBR, TS & E 34 40.88 
Total 69  
Phase III E 17 28.38 
TS (Osteotome) & E 7 37.07 
BBR & E 12 40.92 
BBR, TS & E 35 37.80 
Total 71  
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Table 12 Mean Rank VAS Scores/ Surgical Technique: Bupivacaine 
 Bupivacaine N Mean Rank 
Phase I E 19 45.11 
TS (Osteotome) & E 7 24.14 
BBR & E 17 41.62 
BBR, TS & E 38 41.78 
Total 81  
Phase II E 18 29.94 
TS (Osteotome) & E 7 29.21 
BBR & E 11 32.59 
BBR, TS & E 33 39.79 
Total 69  
Phase III E 18 27.86 
TS (Osteotome) & E 7 37.00 
BBR & E 13 42.92 
BBR, TS & E 34 38.51 
Total 72  
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4.3.3 Surgical Time 
Surgical time was recorded by the surgeon for both the left and right side, Table 13. The 
difference between the two sides was computed and the difference between bupivacaine 
and lidocaine sides was also computed. There were at most ten distinct different values, 
because time was measured to the nearest minute, and therefore normality was assessed 
graphically. Histograms of both difference variables looked symmetrical and approximately 
normal and the Q-Q plot was acceptable.  When analysed according to right versus left side, 
and bupivacaine versus lidocaine, no statistical difference was found between the mean 
surgical times p= 0.325 and p= 0.552 respectively, Table 14. 
Table 13 Descriptive Statistics Surgical Duration (mins) 
 Mean N Std. Deviation 
Right Third Molar Surgical 
Duration in minutes 
4.15 85 1.524 
Left Third Molar Surgical 
Duration in minutes 
4.31 85 1.834 
Bupivacaine Surgical 
Duration (mins) 
4.24 85 1.681 
Lidocaine Surgical 
Duration (mins) 
4.33 85 1.707 
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Table 14 Paired Samples T-Test; Surgical Duration (mins) 
Difference in minutes Mean Std. Error 95% Confidence 
Interval- Lower 
95% Confidence 
Interval- Upper 
t df Sig. (2-
tailed) 
RTM -  LTM                    
Surgical Duration 
-.153 .155 -.460 .154 -.990 84 .325 
Bupivacaine-
Lidocaine Surgical 
Duration 
-.094 .158 -.407 .219 -.597 84 .552 
 
4.4 Post- operative Assessment 
4.4.1 Pain Assessment: Visual Analogue Scale 
Patients were asked to indicate their level of pain by marking a 100mm VAS. This was 
carried out by the patient on three occasions prior to discharge; immediately post-op, 30 
minutes and 1 hour post awakening fully from the general anaesthetic. The patients were 
given four additional VAS to complete at 3, 4, 6 and 8 hours. These were returned at a later 
date. For analysis, the variables were separated into 2 groups; bupivacaine (long acting side) 
and lidocaine (short acting side). The pattern of VAS scores over time was examined, Figure 
1 and it was decided to sub-divide the scores into 3 distinct phases for analysis and to reflect 
patient’s changing situation, 
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Phase I-  VAS scores recorded up to 1hr post-op (i.e prior to discharge) 
Phase II- Vas scores from 3- 8 hours post-op 
Phase III-  Vas scores from day 1- day 7 post-op. 
Figure 1 demonstrates a more noticeable upward trend in median VAS scores for the 
lidocaine group at 3hr and 4hrs post-op. 
Figure 1 Median VAS scores of phases I and II 
 
 
Average VAS scores per patient were calculated for each of the three phases when complete 
data within a phase was recorded.  An example of the highly skewed distribution of VAS 
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scores seen during the three phases is shown in Figure 2. Summary VAS statistics and mean 
pain levels for each side are outlined in Table 15. 
Figure 2  Histogram demonstrating skewed distribution of VAS scores 
 
 
Table 15 Summary Statistics for VAS Phase I & II 
PAIN ANAESTHETIC 
AGENT 
N MEAN MEDIAN MIN MAX 
Phase I Bupivacaine 83 12.65 5.7 0 78.1 
 Lidocaine 83 10.84 6.8 0 54.0 
Phase II Bupivacaine 71 16.38 8.4 0 93.3 
 Lidocaine 71 22.32 14.6 0 95.8 
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Differences between VAS scores for bupivacaine and lidocaine sides were computed (short 
acting side minus long acting side) and tested for normality.  Normality was rejected for 
phase I (see Figure 3 & Table 16).  Differences based on log transformations were also 
rejected for normality.  Comparisons between bupivacaine and lidocaine sides were 
compared using a bootstrap paired samples test. 
 
Table 16 Shapiro-Wilk Normality Testing 
 
Shapiro-Wilk 
Statistic df Sig. 
Difference Phase I .907 83 .000 
Difference Phase II .967 71 .059 
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Figure 3 Graphical Representation of Rejection of Normality 
 
 
 
Phases I and II:  
Two patients had missing/ incomplete data for phase I VAS scores, and 14 had 
missing/incomplete data for phase II. No statistically significant difference was revealed in 
phase I with P>.05. A statistically significant reduction in pain was found when bupivacaine 
was compared to lidocaine during phase II, P=0.001. The mean difference was 5.94 and the 
upper confidence interval for phase II was 9.04, Table 17.  
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Table 17 VAS Bootstrap for Paired Samples Test 
VAS N 
Long 
Mean 
Short 
Mean 
Mean 
Difference 
Short-Long 
Bootstrap 
 95% Confidence Interval 
Std. Error 
Sig. (2-
tailed) Lower Upper 
Phase I 83 12.65 10.84 -1.81 1.46 .222 -4.75 1.02 
Phase II 71 16.38 22.32 5.94 1.65 .001 2.81 9.04 
 
Mean Differences for VAS during the 3hr to 8 hrs of phase II are given in Table 18 to identify 
the time when largest difference between lidocaine and bupivacaine occurred. The sample 
size was determined using a 10mm difference which was considered large enough for the 
longer acting anaesthetic to be considered useful in pain relief post-surgery.  The upper limit 
of the 95% confidence interval was 10.0 or above at 3hours and 4 hours post-surgery. 
 
Table 18 Mean Differences and 95% Bootstrap Confidence Intervals of Phase II VAS 
during 3hr to 8h post-surgery. 
VAS 
Mean 
Difference 
Short-long 
N=71 
Std. 
Error 
Bootstrap 
95%Confidence Interval 
Lower Upper 
3hr 6.61 1.80 3.17 10.01 
4hr 8.39 2.30 3.99 12.91 
6hr 5.01 1.87 1.68 8.44 
8hr 4.00 2.06 -0.24 7.98 
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4.4.2  Effect of Third Molar Orientation on VAS Scores 
Winter’s classification and surgical type were assessed for both lidocaine and bupivacaine 
sides in terms of pain during the three phases. The null hypothesis was accepted indicating 
that surgical technique and Winter’s classification did not impact on VAS scores in either 
group during each of the three phases 
4.4.3  Post-Operative Pain Catastrophizing Scale 
The PCS was repeated prior to discharge to assess if the presence or possibility of pain 
impacted on scoring. See Figure 4 for graphical comparison of pre- and post-operative PCS 
scores. The difference between the scores pre-op minus post-op was computed and its 
distribution tested for normality. Normality was rejected (Shapiro Wilk; p=.006) and the 
bootstrap for Paired Samples Test was performed. Scores were considerably lower post-
operatively (mean = 8.81) when compared to the pre-operative (mean= 13.1) results, 
P<0.001, Table 19. 
Figure 4:   Pre- and Post-operative PCS Scores 
 
69 
 
Table 19 PCS Bootstrap for Paired Samples Test 
 
N 
PCS Pre 
Mean 
PCS Post 
Mean 
Mean 
Difference 
Pre-Post 
Bootstrap 
 95% Confidence Interval 
Std. Error 
Sig. 
(2-tailed) Lower Upper 
80 13.0 8.81 4.19 0.672 .000 2.90 5.55 
 
4.4.4  Post-Operative Hospital Anxiety and Depression Scale 
The HADS questionnaire was repeated prior to discharge. This was carried out to assess if 
completion of the planned procedure had an impact on anxiety and depression levels of the 
study participants.  Both scores decreased after surgery with anxiety showing a difference 
that was statistically significant (P= 0.025), Table 20.  
Table 20  HADS Pre- and Post-operative 
HADS N 
Pre 
Mean 
Post 
Mean 
Mean 
Differen
ce 
Std. 
Error t 
Sig. (2-
tailed) 
95% 
Confidence 
Interval 
Lower Upper 
 Anxiety 81 3.62 3.07 .543 .238 2.285 .025 .070 1.016 
Depression 81 3.62 3.22 .395 .288 1.372 .174 -.178 .968 
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4.4.5  Post-Operative Short-Form McGill Pain Questionnaire 
The SF-MPQ was repeated prior to discharge. xon Signed Rank Test: p<.001).  and Figure 6 
demonstrate an increase in post-operative sensory and affective SF-MPQ scores.  This 
increase was statistically significant (Wilcoxon Signed Rank Test: p<.001).  
Figure 5 
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Figure 6 
 
 
4.4.6  Effect of Post-Operative Assessments on Pain Scores 
There was no significant correlation found between post-operative PCS and total VAS scores 
for phase I (Spearman’s Rho; 0.212; p= 0.066).  
Greater total Phase I VAS scores were not associated with higher HADS scores for anxiety 
and depression. Spearman’s correlation coefficient, based on original data of VAS phase I 
and HADS post anxiety and depression were rs = 0.193 and rs = 0.072, respectively and both 
were not statistically significant.  
There was a significant correlation between post-operative MPQ scores and total Phase I 
VAS scores, Table 21. 
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Table 21 Correlation MPQ Scores and Total VAS Scores for Phase I 
Variables Spearman’s rho Sig (2-tailed) 
Post-MPQ (Sensory) 0.438 0.000 
Post- MPQ (Affective) 0.347 0.002 
Total Sum (Sensory + Affective) 0.629 0.000 
 
4.4.7  Dental Visit Satisfaction Scale. 
Patients were asked to fill out a satisfaction survey prior to discharge and on POD 7. The 
survey consisted of 10 items which described different aspects of the dental experience. 
Question 8,”The dentist was too rough when he worked on me” was omitted as the surgery 
was carried out under general anaesthetic and therefore patients could not answer this 
question. Each question was rated using a score from one to five, with higher scores 
representing greater levels of satisfaction. Compliance rate for completion and return of the 
7 day DVSS was 78% (66/85).  
Two participants scored 9 and 10 in the discharge DVSS. One of those gave a score of 39 for 
the 1 week DVSS which may indicate that this patient misinterpreted the marking at 
discharge. The other patient did not return the 1 week DVSS. The distribution of DVSS scores 
is presented in Table 22. There were 64 patients with DVSS scores at both stages (outlier 
excluded). The scores at discharge were higher than at 7 day. 
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Table 22  Dental Visit Satisfaction Scores (DVSS) at discharge and 7 days 
Scores Discharge DVSS Day 7 DVSS 
9-10 2 (2%) 0 (0%) 
28-30 0 (0%) 2 (3%) 
31-35 3 (4%) 5 (8%) 
36-40 14 (18%) 18 (27%) 
41-45 61 (78%) 41 (62%) 
Total 80 (100%) 66 (100%) 
 
Normality of the DVSS difference was rejected due to kurtosis and by the Normal Q-Q Plot 
(Figure 7). The bootstrap for Paired Samples Test was performed. A small but significant fall 
in satisfaction was seen between discharge and one week post-surgery (p=.007), Table 23. 
Figure 7 Graphical Representation of Rejection of Normality 
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Table 23 DVSS Bootstrap for Paired Samples Test 
N 
Discharge 
DVSS Mean 
7 Day        
DVSS Mean 
Mean Difference  
Discharge-7 Day 
Bootstrap 
 95% Confidence Interval 
Std. Error 
Sig.           
(2-tailed) Lower Upper 
64 
42.66 
(Std Dev 
3.143) 
41.28 
 (Std. Dev 
4.351) 
1.375 0.481 .007 0.462 2.281 
 
A free comment was left by 36% of patients at 7 days. Negative comments related to the 
presence of pain/infection, and aspects relating to medication. A longer than expected 
recovery time was also cause for complaint. For example: 
“I didn’t realise that I would have pain for 2 weeks after the procedure. I wasn’t prepared for 
the length of time I would have discomfort eating”  
Preference regarding long- and short-acting anaesthetics was conflicting with some patients 
wishing to have pain rather than be numb. 
 “I would prefer to feel the pain. I got a shock Tuesday early hours when the freeze wore off. 
Feel I would have dealt with the pain better”.  
“Longer lasting freeze much better as it didn’t wear off till 2.30am the next day so the pain 
killers and anti-inflammatories had taken an effect in my system. With the shorter freeze 
only seemed to be home about an hour and the pain was there” Preferred long lasting 
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Reference to the persistent presence of numbness to the lip/ tongue was made by three 
patients. This was confused with the use of a long lasting anaesthetic on that side.  
“Why is my tongue still numb, if not I would choose the longer lasting one”. 
A number of the comments were of a positive nature. A sample of these is reported here: 
“Very happy with the care I received. The nurses and staff were very friendly and made me 
feel completely at ease 
“Whichever one was used on the LHS because I had least pain there L side” = lidocaine” 
“Very good thorough care. Nurses were kind and sympathetic. Pain peaked after 2-3 days 
but medication was effective in relieving pain. Was thoroughly advised on what to expect. All 
in all very happy” 
“I was very happy with the procedure overall. I was given good pain relief and was hardly 
ever in pain” 
4.4.8  Patient Preference 
Patients were asked to indicate which side (right or left) they preferred on two occasions 
during the first day: prior to discharge and at the end of the day. After 1 week, patients 
were again asked to indicate their preference, this time regarding the long or short acting 
anaesthetic (Table 24).  Approximately two-thirds of patients stated that they preferred 
bupivacaine one week post-op.   
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Table 24 Patient preference 
 Lidocaine/  
Short-acting 
Bupivacaine/  
Long- acting 
No Preference 
Discharge 27% 36.5% 36.5% 
End of day of 
surgery 
36% 61% 3% 
1 week post-op 30% 67% 3% 
 
Patients who preferred bupivacaine had higher scores on the ‘short acting’ side than on the 
‘long acting’ side.  For those who preferred lidocaine they experienced similar pain levels on 
both sides (see Table 25 and Table 26). However the mean Vas scores were similar for both 
preference groups for the ‘long side’ (16.33 vs 17.39). 
Table 25  VAS Bootstrap for Paired Samples Test for patients with a preference for 
Bupivacaine 7 days post-surgery. 
VAS N 
Long 
Mean 
Short 
Mean 
Mean 
Difference 
Short-Long 
Bootstrap 
 95% Confidence Interval 
Std. 
Error 
Sig. (2-
tailed) Lower Upper 
Phase I 47 13.00 12.51 -0.49 2.04 .812 -4.82 3.55 
Phase II 45 16.33 25.04 8.71 2.23 < .001 4.40 13.06 
Phase III 46 28.15 30.23 2.08 3.15 .517 -4.49 8.28 
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Table 26  VAS Bootstrap for Paired Samples Test for patients with a preference for 
Lidocaine 7 days post-surgery. 
VAS N 
Long 
Mean 
Short 
Mean 
Mean 
Difference 
Short-Long 
Bootstrap 
 95% Confidence Interval 
Std. 
Error 
Sig. (2-
tailed) Lower Upper 
Phase I 22 8.90 7.70 -1.20 2.27 .603 -5.91 3.52 
Phase II 22 17.39 18.24 0.86 2.10 .687 -3.50 5.22 
Phase III 22 26.01 27.72 1.72 2.74 .537 -3.97 7.41 
 
4.4.9  Pain Diary 
Patients were asked to record pain experience for both right and left sides on one occasion 
for seven days post- surgery (phase III). For continuity, this was analysed according to the 
anaesthetic administered, Figure 8. Twelve patients had missing data for phase III. 
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Figure 8 Median VAS scores of phases III 
 
Differences between VAS scores for bupivacaine and lidocaine sides were computed (short 
acting side minus long acting side) and tested for normality.  Normality was rejected 
(Shapiro- Wilk= .920).  Summary VAS statistics and mean pain levels for each side are 
outlined in Table 27. 
Table 27 Summary Statistics for VAS Phase I & II  
Pain Anaesthetic  
Agent 
N Mean Median Min Max 
Phase III Bupivacaine 73 26.76 22.7 0 94.7 
 Lidocaine 73 28.32 23.0 0 90.1 
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Comparisons between bupivacaine and lidocaine sides were compared using a bootstrap 
paired samples test. No statistically significant difference was revealed in phase III with 
P>.05, Table 28. 
Table 28 VAS Bootstrap for Paired Samples Test   
VAS N 
Long 
Mean 
Short 
Mean 
Mean 
Difference 
Short-Long 
Bootstrap 
 95% Confidence Interval 
Std. Error 
Sig. (2-
tailed) Lower Upper 
Phase III 73 26.76 28.32 1.56 2.19 .483 -2.73 5.72 
 
Pain diaries (Appendix VIII) were returned by 74 patients (86%) of patients via post. 
Question 1 of the pain diary related to the presence of post-operative pain. Of those who 
returned the pain diary, 64% of patients stated they had pain on POD 7.  
Daily Activities were unaffected by pain in 16% of patients, while 25% of patient’s daily 
activities continued to be affected 7 days post-surgery. 5% of patients complained of pain 
which began affecting daily life between days 4-7. All of these patients visited a GDP/GP 
during this time period. Symptoms of morbidity were recorded by 77% of patients of which 
66% complained of difficulty eating. Inability to work, attend school/college and speak 
normally were the most common complaints reported. 
Of those who returned their pain diary, 32% visited a health care professional during the 7 
days post-surgery, 70% of these were between days 3-5. Two of these patients were 
smokers, with a third patient having ceased smoking 1 month prior to surgery. 
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Patients were asked to record analgesic consumption during the post-operative period, 
Table 29. The recommended prescription of paracetamol, dexketoprofen and oxynorm on 
day was followed by 41% of patients. This reduced to 8% by day 7. Unprescribed analgesics 
rose from 4% on day 1 to 19% on day 7. Analgesics continued to be consumed by 82% of 
patients on day 7.  
Table 29 Analgesic consumption during 7 days post- surgery   
DAY 1 2 3 4 5 6 7 
PARACETAMOL + 
DEXKETOPROFEN + 
OXYNORM 
41% 43% 41% 31% 
 
15% 
 
12% 8% 
PARACETAMOL ± 
DEXKETOPROFEN ± 
OXYNORM 
 
52% 
 
49% 
 
50% 
 
54% 
 
66% 
 
60% 
 
55% 
 
TOTAL PRESC 
 
93% 
 
92% 
 
91% 
 
85% 
 
81% 
 
72% 
 
63% 
 
OTHER MEDS 
 
4% 
 
5% 
 
6% 
 
12% 
 
14% 
 
23% 
 
19% 
 
NIL MEDS 
 
3% 
 
3% 
 
3% 
 
3% 
 
5% 
 
5% 
 
18% 
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5.0 DISCUSSION 
5.1 Study Design 
This study was designed as a split-mouth randomised clinical trial. The patient acted as their 
own control. Both anaesthetic agents were used on the same patient at the same time 
under the same operating conditions. This study design has the advantage of limiting inter-
individual variability and greatly enhances the statistical power.  A study sample of 80 was 
required to detect a difference of 10mm in VAS between bupivacaine and lidocaine ensuring 
90% power at the 5% level of significance and allowing for non-compliance rate of 30%. 
While split-mouth trials have been criticised due to “spill over” effects of the treatment and 
treatments being carried out at different times, this study was designed to prevent these 
flaws (23). The prerequisites for successful use of this study design were met as the 
treatments were double blinded, localised and short lived (195). 
Giving due consideration to the effect of general anaesthesia on motor and cognitive ability, 
all questionnaires and VASs were simply presented avoiding use of technical or medical 
jargon. 
5.2 Sample Characteristics 
 There were 85 patients included in the study. Age ranged from 16 to 44 with median age of 
20.3. 95% of patients were less than 30 years. This corresponds with similar studies and 
reflects the fact that wisdom teeth generally cause problems during eruption between ages 
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18-25 (196). In our department, patients undergoing orthognathic surgery require 
prophylactic removal of third molars which contributed to the proportion of 16-20 year olds 
(54%) having third molars removed. 
Females accounted for 70% of the study participants. Females are believed to have a greater 
discernment of physical disharmony and are more likely to seek treatment compared to 
their male counterparts (197). There was no difference in post-operative pain between 
males and females in this study. 
This study was limited to ASA I and II patients. 91% of participants were ASA grade I which 
reflects the young population captured. There was no correlation between age and ASA 
grade. Smoking rates for this group of participants were low and therefore no definitive 
conclusions could be drawn between the association of smoking and ASA grade. 
There was a high response rate for the seven day pain diary with 86% of patients returning 
the diary via post. This may have been due to patients being supplied with a stamped 
addressed envelope at discharge and contacted during their recovery. Studies have shown a 
higher response rate when postal mail with monetary incentives / stamped addressed 
envelopes are used and follow-up contact is made (198, 199).  As 95% of study participants 
in this study were <30 years, a web survey may have yielded similar response rates with less 
financial implications (200). 
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5.3 Psychological variables 
Non-surgical factors including individual and demographic factors have been shown to 
impact on pain experience(24). Individual factors include psychological variables such as a 
predisposition to catastrophize, as well as baseline levels of anxiety and depression. These 
were recorded in this study to assess if they had an influence on pain levels. 
In 1976, Beck et al. discussed catastrophizing in terms of “dwelling on the worst possible 
outcome of any situation in which there is a possibility for an unpleasant outcome” (201). 
Catastrophizing is thought to comprise of elements of rumination, magnification and 
helplessness.  These components constitute the 13 items of the PCS, developed by O 
Sullivan in 1995 which continues to demonstrate adequate internal consistency and 
validity(202). The PCS has been shown to be a predictor of pain in many settings including 
acute, chronic, diagnostic and experimental pain studies(203). The PCS was used pre- and 
post-operatively in this study to detect if increased scores were associated with higher pain 
scores in the immediate post-operative period. A total score of ≥30 is thought to be clinically 
relevant(119). High PCS scores were not associated with greater Phase I VAS scores in this 
study.  
Any surgery, including third molar removal can be stressful for a patient. The association 
between anxiety and pain is not a new one with several studies showing a positive 
correlation between greater levels of anxiety and post-operative pain (25-27). It is important 
that anxiety prior to third molar surgery is addressed in order to foresee potential 
difficulties in the intra and post-operative period. The Hospital Anxiety and Depression Scale 
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is a valid tool(112) which aims to identify patients experiencing greater levels of anxiety and 
depression. A score of 0-7 is considered normal. 8-10 is considered borderline, with a score 
> 11 representing psychological morbidity. 
Patients in this study completed a HADS pre- and post-operatively. Six patients were 
considered borderline for an anxiety trait, with seven borderline for depression. Two 
patients scored >11 for depression. When repeated prior to discharge, a statistically 
significant reduction in anxiety scores was seen. This is likely to be due to patients feeling 
less anxious on completion of the surgery. There was no statistical difference in depression 
scores. 
This study did not reveal an association between greater pain scores and HADS anxiety and 
depression scores. The sample size when considering psychological variables does not 
compare to large studies to detect such an association(112). Some post-surgical studies 
continue to monitor anxiety and depression for a longer duration than here(27). Continuing 
to do so may have demonstrated changes as pain decreased or increased for the first post-
operative week. 
Use of the PCS and HADS did not yield any unexpected results and may suggest their 
application in relatively small studies such as this may not be advantageous. Completion of 
these questionnaires prior to discharge is challenging for patients recovering from surgery 
and a general anaesthetic. 
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5.4 Pre-operative pain assessment 
Third molars can cause pain due to the same reasons that warrant their extraction; caries, 
associated pathology and pericoronitis. As previously mentioned pain is multifaceted with 
patient age and gender as well as surgery type impacting on the level of post-operative pain 
experienced (204). Baseline pain levels were taken to assess if greater pre-operative pain 
was associated with greater post-operative pain. The short-form McGill Pain Questionnaire 
(SF-MPQ) was used in this study. This version is less arduous than the original which has 78 
pain descriptors. The SF-MPQ takes on average 2-5 minutes to complete(205) and its validity 
has been repeatedly proven for different disciplines (160, 206). It consists of 15 descriptors 
of pain which are rated on an intensity scale. 11 of these are sensory descriptors while the 
remaining 4 are affective terms. Each question was scored from 0-3 with a maximum score 
of 33 for the sensory subset, and a maximum of 12 for the affective subset. A majority of 
patients reported an absence of pre-operative pain.  
5.5 Assessment of difficulty and technique of third molar surgery 
All 85 patients included in this study had bilateral similarly impacted lower third molars. Not 
all were symmetrical according to Winter’s classification. 16 cases were asymmetrical. The 
confounding factor of multiple operators was removed by this study design. Surgical 
duration which has been shown to impact on post-operative pain (207) was less variable by 
having a single experienced maxillofacial surgeon complete all extractions. 
No significant difference was seen in the mean surgery time for removal of right and left 
molars for the total group. Statistical analysis was also performed to compare surgical 
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duration (minutes) of the bupivacaine versus lidocaine side. No statistical difference was 
found between the two groups.  
5.6 Post-operative pain assessment 
 The SF-MPQ was repeated prior to discharge. Statistically significant differences were found 
between pre- and post-operative MPQ scores for sensory and affective pain. Third molar 
surgery is associated with post-operative pain despite a combination of analgesics and local 
anaesthetics. The difference in pain was expected as most patients reported an absence of 
pain pre-operatively. “Mild” pain (total sum sensory and affective) was reported by 95.2% of 
patients. This differs from similar research where “moderate” or “severe” pain is frequently 
reported (104).  
The visual analogue scale (VAS), the verbal rating scale (VRS) and numeric pain scale (NPS) 
are the most commonly used scales to assess pain intensity. Each have their own 
advantages and disadvantages. The VAS while more technically challenging compared to the 
VRS and NPS, can be analysed using parametric tests and is therefore the preferred method 
in many scientific papers (208). In this study, pain intensity for both left and right sides was 
assessed using a VAS on three occasions prior to discharge. It was reassessed on four further 
occasions post discharge. No significant difference in pain intensity was found between the 
sides prior to discharge (phase I). A significant difference in pain was found during phase II 
(3-8hrs), when pain was significantly less on the side treated with bupivacaine. Maximum 
differences between the groups was seen three- four hours post-op. This finding supports 
similar studies (18) (92) demonstrating that longer periods of analgesia can be achieved with 
87 
 
longer acting anaesthetics such as bupivacaine. This supports its use for oral surgical 
procedures generally associated with significant persistent postoperative pain. 
Bupivacaine is widely available as a plain solution or with adrenaline (1:200 000) in 10ml 
glass ampoules. Its unopened shelf life is two years. Bupivacaine with epinephrine is 
available in 1.8mL cartridges. The average dose of 1.8 mL (9 mg) per injection site will 
usually suffice; an occasional second dose of 1.8 mL (9 mg) may be used if necessary to 
produce adequate anaesthesia after making allowance for 2 to 10 minutes onset time. It is 
recommended that the total dose for all injection sites, spread out over a single dental 
sitting, should not ordinarily exceed 90 mg for a healthy adult patient (ten 1.8 mL injections 
of 0.5% bupivacaine HCL with epinephrine).  
A VAS for right and left sides was completed by each patient once daily for seven days. 
Figure 2 illustrates that pain on the bupivacaine and lidocaine sides peaked on day 2. This 
conflicts with other studies which found post-operative pain peaked during the first 24 
hours (56, 209). Pain was identical on both sides on POD 3. 
Median pain scores for either group did not exceed 30mm at any stage during the post-
operative recovery period and could therefore be considered “mild” (210, 211). Analysis of 
returned pain diaries revealed 64% of patients continued to have pain on POD 7. Median 
VAS scores for POD 7 revealed Scores <10mm for both sides which is considered none/mild 
(212). This concurs with similar third molar studies where pain on POD 7 is considered “very 
weak” or “none”(28, 56). Interestingly, 82% of patients continued to take analgesics on POD 
7. This would suggest that 18% of patients either had no pain due to the continued 
consumption of analgesics or patients continue to take analgesics if it has been prescribed 
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for one week despite an absence of pain. A longer follow-up time may be warranted in 
future studies to capture a longer period of patient reported outcomes. 
Symptoms of morbidity were reported by three quarters of patients, of which difficulty 
eating was the main complaint. The median number of days that daily activities were 
affected was 4. Similar studies have found that daily activities are affected and return to 
work delayed for an average of 3 days (29, 30, 213). 
5.7 Post-operative Complications 
Almost a third of patients visited a health care professional during the first post-operative 
week as result of pain +/- infection. The incidence of alveolar osteitis following third molar 
removal varies greatly with a wide range between 1-40% reported in the literature (72). 
Transient paraesthesia affecting the lip/tongue was reported by 3 patients representing 
3.5% of the overall number of research patients. Similar findings were identified in 
comparable studies (72, 74). No further significant post-operative complications occurred. 
5.8 Satisfaction Measures 
Satisfaction in this study was assessed using the Dental Visit Satisfaction Scale at discharge 
and on POD 7. This scale assesses satisfaction using three subscales; 
information/communication, understanding/acceptance and technical competence. 
Patients rate their response to standardised statements on a 5 point scale, each of which is 
allocated a score that can then be analysed. “The dentist was too rough when he worked on 
me” was omitted as patients were not awake during the procedure. In this study a 
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maximum score of 45 reflected complete satisfaction, with a score of 25 regarded as a 
neutral point showing neither satisfaction nor dissatisfaction. All patients scored above this 
neutral point on both occasions. No difference was found between satisfaction scores for 
males and females in this study. 
There was a statistically significant drop in satisfaction scores between discharge and POD 7. 
This is likely due to the deterioration in oral health related quality of life during the 
immediate postoperative period (169). A significant number of patients required medical 
intervention during the first week as a result of pain and infection. Dissatisfaction with the 
explanation of pain expectation and empathy of the dentist in relation to pain were also key 
factors in lower scores on POD 7.  
Studies have shown that thorough explanation regarding post-operative recovery is 
associated with significantly greater inability to work (213), but can improve patient 
satisfaction (170). This issue should be addressed in order to adequately prepare patients in 
our department. 
Patients were given the opportunity to leave a free comment at discharge and POD 7.  A 
greater proportion of comments left at discharge were of a positive nature. This may have 
been due to the effectiveness of the analgesics and local anaesthetics at the time. Negative 
comments on POD 7 were in relation the presence of pain or infection, issues with 
analgesics and a longer than expected recovery time. Patients may have felt more able to 
express dissatisfaction when they were no longer in the company of the research/theatre 
staff. Positive comments related to the standard of care and pre-operative information 
received and the absence of pain.  
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5.9 Patient preference 
Although there has been a vast amount of research using the third molar pain model to 
compare local anaesthetics, patient satisfaction relating to local anaesthetics remains 
equivocal (21, 96, 214, 215). As mentioned previously, the sensation of numbness may not 
be considered pleasant. Some patients may prefer to experience pain rather than have a 
prolonged loss of sensation (96).  
In this study, bupivacaine was the preferred local anaesthetic of choice at discharge, end of 
day of surgery and on POD 7. Preference on POD 7 provides a more conclusive result as 
patients have had adequate time for reflection. When asked “if you were having your 
wisdom teeth removed again, which freeze would you prefer to be used on both sides, 
Short lasting or Long lasting?”, patients were twice as likely to choose a long lasting 
anaesthetic (bupivacaine). 
An equal number of positive and negative comments were left regarding the longer lasting 
numbness. Some expressed a preference for pain over numbness while others preferred to 
be numb rather than experience pain. Two patients commented that the shorter acting 
anaesthetic was preferred due to persistent paraesthesia in the lip/tongue. 
5.10 Limitations and Suggestions for Further Study 
Sample size was calculated using an estimate of the standard deviation of the difference 
between the two groups, lidocaine and bupivacaine. This standard deviation was based on 
unpublished research which compared lidocaine to a control (no LA) and hence was not a 
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directly comparable. For phase II of the study the standard deviation of the difference was 
smaller than the estimated used to compute sample size (13.9 vs 22). Using a smaller 
standard deviation would not have required as many study participants for analysing VAS 
score but would have affected the estimates of other outcome variables. 
  In order to achieve a sufficient sample size, bilateral impacted third molars of similar 
difficulty were included in this study. Due to a greater than expected response rate, these 
unsymmetrical third molars could have been omitted. Statistical analysis however did not 
show significant differences in surgical duration, Winter’s classification or surgical type 
between the groups and therefore all cases were included. Inclusion of unsymmetrical third 
molars added an additional level of complexity to the analysis of results. 
Due to the lack of a research nurse, it was not possible to be in the operating theatre to 
record the time and therefore this was the joint responsibility of the surgeon and assistant. 
Likewise having a research nurse solely responsible to ensure questionnaires and VASs were 
thoroughly completed would have been beneficial. 
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6.0 Conclusion 
A vast amount of research has been carried out on the topic of local anaesthetics for third 
molar surgery. To the best of our knowledge none have directly compared lidocaine to plain 
bupivacaine on the same patient, at the same time under the same operating conditions. 
Patient and operator variabilities are hence minimised by this split mouth design using a 
single operator.  
This research demonstrates that plain 0.5% bupivacaine provides longer analgesia than 2% 
lidocaine with adrenaline. Its use in an out-patient setting would be of particular value 
where pain is often central to delayed discharge. This longer period of analgesia does not 
have a prolonged impact on pain experience during the seven days following surgery.  
Emphasis has been placed on identifying indicators of anxiety, depression and potential to 
catastrophize in pre-surgical patients in order to predict those who may be more susceptible 
to complain of greater pain. These questionnaires did not detect a correlation between 
higher pain scores and pre-operative anxiety/depression and potential to catastrophize. This 
may be a result of the young patient population captured or the relatively small study size. 
Patient satisfaction is key to successful healthcare systems and was central to this study 
through the use of validated questionnaires and free comment sections. A realistic depiction 
of recovery is important to adequately prepare patients for surgery and its aftermath. 
Assessing patient reported outcomes has allowed insight into a patient’s recovery and its 
analysis has the potential to benefit future patients.   
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Following a period of reflection, bupivacaine was the anaesthetic of choice for a greater 
percentage of patients. Some preferred bupivacaine due to the longer period of anaesthesia 
it provided, while others expressed their dislike for the persistent numbness.  
This study supports patient choice with regards to different local anaesthetic agents. 
Selection should be based on the perceived difficulty of surgery, patient variables and 
preference. 
 
 
  
94 
 
8.0 Appendices 
Appendix I 
CONSENT FORM 
CONSENT BY SUBJECT FOR PARTICIPATION IN RESEARCH PROJECT 
 
Protocol Number: _______  Subject Name: ____________________________ 
 
Title of Research Project:  
Comparison between lidocaine and bupivacaine in patients undergoing third molar extraction 
in terms of patient satisfaction 
Investigators:   
Dr. Caroline McCarthy, UCC Dental Hospital, Dept of Oral Surgery 
Prof. Duncan Sleeman, UCC Dental Hospital, Dept of Oral Surgery  
Dr. Paul Brady, UCC Dental Hospital, Dept Of Oral Surgery 
 
You are being asked to participate in a research study.  In order to decide whether or not you 
want to be a part of this research study, you should understand enough about its risks and 
benefits to make an informed judgment.  This process is known as informed consent.  This 
consent form gives detailed information about the research study, which will be discussed 
with you.  Once you understand the study, you will be asked to sign this form if you wish to 
participate. 
Nature and Duration of the procedure: 
The aim of this research is to look at the relationship between the type of local anesthetic used 
and the amount of pain experienced by the patient. You will receive a local anesthetic on one 
side of your mouth that lasts on average 2-3 hours. The anesthetic on the other side will last 
on average 5-8 hours. Both of these are commonly used in dentistry. 
Some pain is expected after wisdom tooth extraction despite being numb. We want to look at 
how satisfied you are with the feeling of numbness for the post-operative period. 
The surgery will be carried out by Prof. D Sleeman. 
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Potential Risks and Benefits: 
There are no additional risks associated with taking part in this study, other than those 
already associated with wisdom tooth removal. You will feel numb on one side of your 
mouth for up to 8 hours and for this reason hot food and drinks should be avoided until 
normal feeling returns. (Standard advice given after extraction(s) is to avoid hot food and 
drink for 24 hours) 
AGREEMENT TO CONSENT 
The research project and the treatment procedures associated with it have been fully 
explained to me.   I have had the opportunity to ask questions concerning any and all 
aspects of the Research Project and any related matters or issues of concern. I am aware 
that my participation is voluntary and that I may withdraw my consent at any time. I am 
aware that my decision not to participate or to withdraw will not restrict my access to health 
care services normally available to me.   
I, the undersigned, hereby consent to participate as a subject in the above described 
Research Project conducted at Cork University Hospital. I have received a copy of this 
Consent Form and Research Subject Information Sheet for my records.  I understand that if I 
have any questions concerning this research, I can contact the investigators listed above.
  
Date: 
 
Signed:  
[Research Subject’s Name] 
Witnessed: 
[Chief Investigator/Co-Investigator] 
Witnessed: 
[Parent/Guardian for Minor Research Subject or Next of Kin for Elderly Patient] 
  
Appendix II        
PT NAME:            PATIENT NO.:                                    PATIENT REF:                           DATE:    
 PLEASE INDICATE HOW BAD YOUR PAIN IS ON EACH SIDE OF YOUR MOUTH 
 PLEASE TICK WHICH SIDE OF YOUR MOUTH YOU PREFER. TICK BOTH IF YOU HAVE NO PREFERENCE.  
LEFT □         RIGHT □ 
      Immediate          
            
LEFT □         RIGHT □    
30 Mins                    
      LEFT □         RIGHT □ 
1 Hr    
     
          
Appendix III         
PT NAME:            PATIENT NO.:                                    PATIENT REF:                           DATE:    
 PLEASE INDICATE HOW BAD YOUR PAIN IS ON EACH SIDE OF YOUR MOUTH 
 PLEASE TICK WHICH SIDE OF YOUR MOUTH YOU PREFER. TICK BOTH IF YOU HAVE NO PREFERENCE.  
LEFT □         RIGHT □ 
      1 Hr        
            
LEFT □         RIGHT □    
3 Hrs                     
      LEFT □         RIGHT □ 
4 Hrs   
     
 LEFT □         RIGHT □ 
             6HR              
LEFT □         RIGHT □ 
                    8HR              
   
1. Did you take painkillers today, to treat pain from your dental surgery? (Please √) 
Yes  □     No □      
Paracetamol  ___ Tablets  Time(s) taken  eg 2.30pm       ______    ______    _____    ______    ______    ______    ______  
 Keral   ___ Tablets Time(s) taken  ______    ______    ______    ______    ______    ______    ______    
 Oxynorm  ___ Tablets Time(s) taken  ______    ______    ______    ______    ______    ______    ______ 
 
2. If you were having your wisdom teeth removed again, which freeze would you prefer to be used on both sides, the anaesthetic used on the  
Left side □  OR  Right side □  (Please √) 
   Please give a reason for your choice____________________________________________________________________________________ 
 Appendix IV 
PAIN CATASTROPHIZING SCALE  
PATIENT REF:         
PT NO.: 
DATE: 
Everyone experiences painful situations at some point in their lives. We are interested in the types of 
thoughts and feelings that you have when you are in pain. Listed below are thirteen statements describing 
different thoughts and feelings that may be associated with pain. Using the following scale, please indicate 
the degree to which youhave these thoughts and feelings when you are experiencing pain. 
0= not at all 1=to a slight degree 2=to a moderate degree 3=to a great degree 4=all the time 
 
 
 
 
 
 Appendix V 
HOSPITAL ANXIETY and DEPRESSION SCALE 
NAME:   
PATIENT NO.:       Date: 
PATIENT REF:   
Tick (√) the box of the answer that is most appropriate to you: 
 Yes definitely Yes sometimes No, not much No, not at all 
1. I wake early then sleep badly 
for the rest of the night 
    
2. I get very frightened or have 
panic feelings for apparently 
no reason at all 
    
3. I feel miserable and sad     
4. I feel anxious when I go out of 
the house on my own 
    
5. I have lost interest in things     
6. I get palpitations, or sensations 
of “butterflies” in my stomach 
or chest 
    
7. I have a good appatite     
8. I feel scared or frightened     
9. I feel life is not worth living     
10. I still enjoy the things I used to     
11. I am restless and can’t keep 
still 
    
12. I am more irritable than usual     
13. I feel as if I have slowed down     
14. Worrying thoughts constantly 
go through my mind 
    
 
  
 
 Appendix VI 
Short Form McGill Pain Questionnaire 
PATIENT NAME:          
PATIENT REF:      DATE: 
PT NO.: 
Please tick (√) the circle for the amount of pain you are experiencing in relation to your mouth 
None  Mild  Moderate  Severe 
Throbbing    ⃝   ⃝        ⃝        ⃝__ 
Shooting    ⃝   ⃝        ⃝        ⃝__ 
Stabbing    ⃝   ⃝        ⃝        ⃝__ 
Sharp     ⃝   ⃝        ⃝        ⃝__ 
Cramping    ⃝   ⃝        ⃝        ⃝__ 
Gnawing    ⃝   ⃝        ⃝        ⃝__ 
Hot-burning    ⃝   ⃝        ⃝        ⃝__ 
Aching     ⃝   ⃝        ⃝        ⃝__ 
Heavy     ⃝   ⃝        ⃝        ⃝__ 
Tender     ⃝   ⃝        ⃝        ⃝__ 
Splitting    ⃝   ⃝        ⃝        ⃝__ 
Exhausting    ⃝   ⃝        ⃝        ⃝__        
Sickening    ⃝   ⃝        ⃝        ⃝__ 
Fearful     ⃝   ⃝        ⃝        ⃝__ 
Punishing    ⃝   ⃝        ⃝        ⃝__ 
 
 
 
 
 Appendix VII 
DENTAL VISIT SATISFACTION SCALE (1 week) 
NAME:   
PATIENT NO.:  
PATIENT REF: 
DATE:   
 
Please circle the most appropriate score for the statements below, using the following scale; 
1- Strongly disagree     
2- Disagree 
3- Neither agree or disagree 
4- Agree 
5- Strongly agree 
 
1. After talking with the dentist, I know what the purpose of my procedure is.  
1 2 3 4 5  
2. After talking with the dentist, I have a good idea what to expect in the next few weeks. 
1 2 3 4 5  
3. The dentist told me all I wanted to know about the procedure. 
1 2 3 4 5  
4. I felt understood by the dentist. 
1 2 3 4 5  
5. I felt that the dentist really knew how upset I was about the possibility of pain. 
1 2 3 4 5  
 
 
 
 
               
         P.T.O 
6. I felt the dentist accepted me as a person. 
1 2 3 4 5  
7. The dentist was thorough in doing the procedure. 
1 2 3 4 5  
8. The dentist was too rough when he worked on me. 
1 2 3 4 5  
9. I was satisfied with what the dentist did. 
1 2 3 4 5  
10. The dentist seemed to know what he was doing during my visit.  
1 2 3 4 5  
 
 
11. If you were having your wisdom teeth removed again, which freeze would you prefer to be used on 
both sides 
Short lasting □  OR  Longer lasting □  (Please √) 
 
Please indicate any further comments on matters associated with your procedure in the box below. 
 
 
 
 
 
 
 
 
  
Appendix VIII 
PAIN DIARY     
 Day __ 
1. Did you have pain that you associate with your dental surgery today (please tick) 
Yes □      No □ 
2. Did pain associated with your dental surgery affect what you could or could not do today? 
  Yes  □     No □ 
If yes, in what way? 
             ____________________________________________________________________ 
 
3. Did you take painkillers today, to treat pain from your dental surgery? 
Paracetamol  ___ Tablets 
Keral   ___ Tablets 
Oxynorm  ___ Tablets 
 
4. Did you need to see a dentist today for complications associated with the surgery? 
 
Yes  □     No □ 
5. Indicate how bad your pain is on the LEFT side of your mouth 
 
 
 
6. Indicate how bad your pain is on the RIGHT side of your mouth 
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